5 月 11 日（金）

日㈮
プログラム

第2日

11

開会式 ST（第 1 会場：仙台国際センター・会議棟

2F

大ホール，9：30〜9：45）

会長講演 ST（第 1 会場：仙台国際センター・会議棟

2F

大ホール，9：45〜10：20）

コホート研究からゲノム医療へ
座長：名古屋大学

吉 川

演者：東北大学八重樫 伸 生史 隆

シンポジウム 1（腫瘍）! ST（第 1 会場：仙台国際センター・会議棟

2F

大ホール，13：15〜16：15）

婦人科がん治療戦略としての個別化医療の展開〜基礎から臨床へ〜
座長：島根大学

京

哲

永 瀬

智

平 沢

晃

豊 島

将 文

馬 場

長

足 立

克 之

座長：東京女子医科大学

松 井

英 雄

演者：和歌山県立医科大学

井 箟

一 彦

山形大学
1）婦人科遺伝性腫瘍およびがんゲノム異常の解析とゲノム医療実用化に向けた取り組み
演者：慶應義塾大学
2）卵巣がんの臨床的特徴をバイオマーカーとした新規治療標的の大規模探索
演者：東北大学
3）高リスク子宮体癌，特に漿液性癌に対する個別化治療法開発に向けた基礎研究
演者：京都大学
4）癌幹細胞の個別化とそれに対応した個別化医療の開発〜子宮頸癌を中心に
演者：埼玉県立がんセンター，東京大学

教育講演 1（第 1 会場：仙台国際センター・会議棟

2F

大ホール，16：20〜16：50）

絨毛性腫瘍の病態と診療―Pitfall に陥らないために―― 57 ―

日㈮
プログラム
11

教育講演 2（第 2 会場：仙台国際センター・会議棟

2F

橘，16：20〜16：50）

婦人科腫瘍における precision medicine の現況と展望
座長：慶應義塾大学

青 木

大 輔

演者：新潟大学

榎 本

隆 之

教育講演 3（第 3 会場：仙台国際センター・会議棟

2F

萩，16：20〜16：50）

サイトメガロウイルス母子感染
座長：宮崎大学

鮫 島浩

演者：神戸大学

山 田

秀 人

生涯研修プログラム 1（第 2 会場：仙台国際センター・会議棟

2F

橘，8：00〜9：20）

思春期悪性腫瘍への対応
座長：千葉大学

生 水

真紀夫

筑波大学

佐 藤

豊 実

演者：聖マリアンナ医科大学

鈴 木直

演者：三重大学

池 田

智 明1）がん・生殖医療における妊孕性温存はどこまで可能か―その適応は？
2）周産期の立場から
3）ヘルスケアの立場から
演者：福島県立医科大学ふくしま子ども・女性医療支援センター
髙 橋

俊 文

座長：慶應義塾大学

田 中

守

岡山大学

増 山

寿

演者：宮城県立こども病院，東北大学

室 月

淳

演者：日本医科大学

中 井

章 人

尾 崎

康 彦

生涯研修プログラム 2（第 3 会場：仙台国際センター・会議棟

2F

萩，8：00〜9：20）

切迫早産の新しい概念と管理法

1）short tocolysis とペッサリーによる新しい切迫早産管理
2）早産予防とプロゲステロン
3）子宮頸管ペッサリーによる切迫早産治療法
演者：名古屋市立大学― 58 ―

（第 4 会場：仙台国際センター・会議棟

2F

桜 1，8：00〜9：20）

11

不妊症の up to date
座長：秋田大学

寺 田

幸 弘

帝京大学

綾 部

琢 哉

演者：滋賀医科大学

木 村

文 則

演者：山王病院藤 原

敏 博

演者：東北大学立 花

眞 仁1）慢性子宮内膜炎の病態
2）黄体機能不全の病態と治療
3）男性不妊と顕微授精と次世代

生涯研修プログラム 4（第 2 会場：仙台国際センター・会議棟

2F

橘，10：30〜11：50）

家族性・遺伝性腫瘍
座長：東北医科薬科大学

渡 部

洋

久留米大学

牛 嶋

公 生

関 根

正 幸

佐 藤

直 樹

植 木

有 紗

座長：日本医科大学

竹 下

俊 行

岩手医科大学

菊 池

昭 彦

夫

律 子

1）遺伝性卵巣がんの診療とサーベイランス
演者：新潟大学
2）遺伝性・家族性腫瘍としての子宮体癌〜リンチ症候群を中心に〜
演者：秋田大学
3）遺伝性婦人科癌に対する遺伝カウンセリング
演者：慶應義塾大学

生涯研修プログラム 5（第 3 会場：仙台国際センター・会議棟

2F

萩，10：30〜11：50）

胎児疾患の超音波診断

1）胎児脳異常診断のコツと裏技
演者：クリフム夫律子マタニティクリニック
2）胎児心臓超音波検査初級から上級まで
演者：昭和大学

松 岡

演者：山形大学

堤隆3）胎児の骨系統疾患― 59 ―

日㈮プログラム

生涯研修プログラム 3

誠 司

日㈮
プログラム
11

生涯研修プログラム 6（第 2 会場：仙台国際センター・会議棟

2F

橘，17：00〜18：20）

婦人科がん手術のための手術解剖学
座長：京都大学

万 代

昌 紀

福井大学

吉 田

好 雄

演者：札幌医科大学

齋 藤豪

演者：東北大学

新 倉

仁

小 林

裕 明

1）手術解剖からみた腟式手術
2）リンパ流を意識した手術解剖学
3）腹腔鏡・ロボット広汎子宮全摘出術に必要な手術解剖：他科骨盤外科との比較から
演者：鹿児島大学

生涯研修プログラム 7（第 3 会場：仙台国際センター・会議棟

2F

萩，17：00〜18：20）

周産期メンタルヘルス
座長：川崎医科大学

下 屋

浩一郎

防衛医科大学校古 谷

健 一

演者：葛飾赤十字産院

鈴 木

俊 治

演者：大阪母子医療センター

光 田

信 明

演者：順天堂大学越谷病院メンタルクリニック

鈴 木

利 人

1）周産期メンタルヘルス診療指針 20172）妊産婦の自殺を防ぐために
3）向精神薬と妊娠・授乳会長特別企画 1 !
（第 1 会場：仙台国際センター・会議棟

2F

大ホール，17：00〜18：20）

災害時の周産期医療と危機管理
座長：北里大学

海 野

信 也

杏林大学

岩 下

光 利

演者：東北大学

菅 原

準 一

演者：久留米大学

津 田

尚 武

坂 口

勲

1）災害時の周産期危機管理
2）災害時の周産期ネットワーク
3）熊本地震が周産期医療に及ぼした影響
演者：熊本大学― 60 ―

（第 1 会場：仙台国際センター・会議棟

2F

大ホール，8：20〜9：20）

11

臨床研究に関する法令において研究者と組織が対応すべきこと
座長：徳島大学苛 原稔

演者：東北大学

高 野

忠 夫

医療倫理講習会 !（ビデオ上映・事前登録制）（第 17 会場：東北大学百周年記念会館

2F

川内萩ホール，13：30〜14：30）

臨床研究に関する法令において研究者と組織が対応すべきこと

医療安全講習会 !（事前登録制）（第 1 会場：仙台国際センター・会議棟

2F

大ホール，10：40〜11：40）

医療安全（事例紹介）
座長：京都府立医科大学

北 脇城

演者：群馬大学

峯 岸敬

医療安全講習会 !（ビデオ上映・事前登録制）（第 17 会場：東北大学百周年記念会館

2F

川内萩ホール，14：50〜15：50）

医療安全（事例紹介）

海外招請講演 1（第 12 会場：仙台国際センター・展示棟

会議室 1，10：40〜11：10）

Precision Medicine：New Frontier in Womenʼs Health
Chair：The University of Tokyo

Yutaka Osuga

Speaker：University of California, USA

Linda Giudice― 61 ―日㈮プログラム

医療倫理講習会 !（事前登録制）

日㈮
プログラム
11

海外招請講演 2（第 13 会場：仙台国際センター・展示棟

会議室 2，10：40〜11：10）

Genetics of Pre!eclampsia
Chair：Saitama Medical Center, Saitama Medical University
Hiroyuki Seki
Speaker：Tampere University Hospital, Finland
Hannele Laivuori

海外招請講演 3（第 12 会場：仙台国際センター・展示棟

会議室 1，11：10〜11：40）

Reducing the Rate of Preterm Birth !Results of a State!
wide Implementation Program
Chair：Mie University

Tomoaki Ikeda

Speaker：The University of Western Australia, Australia
John Newnham

海外招請講演 4（第 13 会場：仙台国際センター・展示棟

会議室 2，11：10〜11：40）

Personalized Cancer Models for Discovery and Development of Novel Therapeutic Targets
Chair：Osaka Medical College

Masahide Ohmichi

Speaker：Fred Hutchinson Cancer Research Center, USA
Christopher Kemp

海外招請講演 5（第 13 会場：仙台国際センター・展示棟

会議室 2，16：20〜16：50）

How Has Our Understanding of Abnormal Uterine Bleeding（AUB）Changed during the Last Decade?
Chair：Nihon University

Kei Kawana

Speaker：Ninewells Care Mother and Baby Hospital, Sri Lanka
Rohana Haththotuwa― 62 ―

（第 14 会場：仙台国際センター・展示棟

会議室 3，16：20〜16：50）

11

Optimisation of Antenatal Steroid Therapy
Chair：University of Miyazaki

Yuki Kodama

Speaker：The University of Western Australia, Australia
Matthew Kemp

海外招請講演 7（第 15 会場：仙台国際センター・展示棟

会議室 4，16：20〜16：50）

A Search Engine of Personalized Treatments for Ovarian Cancer
Chair：Kyushu University
Speaker：SEngine Precision Medicine, USA

Kiyoko Kato
Carla Grandori

海外招請講演 8（Web 講演）（第 12 会場：仙台国際センター・展示棟

会議室 1，17：00〜17：30）

Screening and Prevention of Preeclampsia
Chair：University of Toyama
Speaker：Kingʼs College London, UK

Shigeru Saito
Kypros Nicolaides

海外招請講演 9（第 13 会場：仙台国際センター・展示棟

会議室 2，17：30〜18：00）

Management of Preterm Labor, Delivery and Newborn at National Hospitals in Cambodia
Chair：Osaka University

Tadashi Kimura

Speaker：Cambodian Society of Gynecology and Obstetrics,
Cambodia

Sann Chan Soeung

海外招請講演 10（第 14 会場：仙台国際センター・展示棟

会議室 3，17：30〜18：00）

Prenatal Programming, Epigenetics and Transgenerational Outcomes
Chair：Hiroshima University

Yoshiki Kudo

Speaker：University of Toronto and The Lunenfeld!
Tanenbaum
Research Institute, Sinai Health Systems, Canada
Stephen Matthews― 63 ―

日㈮プログラム

海外招請講演 6

日㈮
プログラム
11

海外招請講演 11（第 15 会場：仙台国際センター・展示棟

会議室 4，17：30〜18：00）

Gene Correction in Human Embryos
Chair：Akita University

Yukihiro Terada

Speaker：Center for Embryonic Cell and Gene Therapy, Oregon
Health ＆ Science University, USA
Shoukhrat Mitalipov

日韓台ジョイントカンファレンス（2nd J-K-T Joint Conference）① !
（第 5 会場：仙台国際センター・会議棟

2F

桜 2，10：30〜11：10）

Opening Remarks
Speaker：The University of Tokyo/JSOG Chairperson
Tomoyuki Fujii
Kuo General Hospital/TAOG President
Tsung-Cheng Kuo
1．周産期（Perinatology）
Chair：Osaka University/JSOG

Tadashi Kimura

Ewha Womans University/KSOG

Woong Ju

1）Acute Myometritis in Refractory Postpartum Hemorrhage：The Underlying Pathology and theDevelopment of Novel Treatment for Uterine!
type Amniotic Fluid Embolism
Speaker：Hamamatsu University School of Medicine/JSOG
Naoaki Tamura
2）Comparison of Various Markers for Intrauterine Growth Restriction/Small!
for!gestational Age Fetusesin the First Trimester
Speaker：MacKay Memorial Hospital/TAOG

Chen-Yu Chen

3）Maternal Anti!Fetal Rejection As a New Mechanism of Spontaneous Preterm Birth
Speaker：Yonsei University/KSOG（第 5 会場：仙台国際センター・会議棟

2F

JoonHo Lee

桜 2，11：10〜11：50）

2．不妊（Reproduction）
Chair：Kyushu University/JSOG
MacKay Memorial Hospital/TAOG

Kiyoko Kato
Wen-Chu Huang

1）Current Status of Uterus Transplantation Research in Japan：Towards Clinical Application
Speaker：Keio University/JSOG

Iori Kisu

2）Roles of Exosome!Associated Glycosphingolipids in Immune Tolerance of Embryo Implantation andPregnancy
Speaker：Chang Gung Memorial Hospital Linkou Medical Center/
TAOG― 64 ―

Hsien-Ming Wu3）Fertility Preservation in Gynecologic Cancer Patients
Speaker：Cheil General Hospital ＆ Womenʼs Healthcare Center,
Chan Woo Park

日韓台ジョイントカンファレンス（2nd J-K-T Joint Conference）② !
（第 5 会場：仙台国際センター・会議棟

2F

桜 2，17：00〜17：30）

海外招請講演The Most Important Discoveries of the Past Fifty Years in Gynecologic Pathology
Chair：Iwate Medical University/JSOG

Toru Sugiyama

Speaker：Professor Emeritus of Pathology, University of
Maryland, USA（第 5 会場：仙台国際センター・会議棟

2F

Steven Silverberg

桜 2，17：30〜18：10）

3．婦人科腫瘍（Gynecology）
Chair：Seoul National University/KSOG

Jae-Weon Kim

China Medical University ＆ Hospital/TAOG
Wei-Chun Chang
1）Integrated Analysis of Genomic and Transcriptomic Data in Ovarian Clear Cell Carcinoma
Speaker：Niigata University/JSOG

Kosuke Yoshihara2）Discovery and Translation of Epigenetic Biomarker in Womenʼs Cancers
Speaker：Shuang Ho Hospital/TAOG

Hung-Cheng Lai

3）HOXB9 as a Potential Target Gene for Overcoming Platinum Resistance in Mucinous Ovarian Cancer
Speaker：Seoul National University/KSOG

Dong Hoon Suh

Closing Remarks
Speaker：Ewha Womans University/KSOG Chairman
Seung Cheol Kim
Fu Jen Catholic University Hospital/TAOG Honorary
Fellow
Ching!Hung Hsieh

ランチョンセミナー 5（第 1 会場：仙台国際センター・会議棟

2F

大ホール，12：00〜13：00）

血管，尿管周囲操作はこうする！〜腹腔鏡下婦人科悪性腫瘍手術〜
共催：ジョンソン・エンド・ジョンソン株式会社
座長：京都大学

万 代

演者：奈良県立医科大学

棚 瀬

康 仁

太 田

啓 明

倉敷成人病センター― 65 ―

昌 紀

日㈮
プログラム

Dankook University College of Medicine/KSOG

11

日㈮
プログラム
11

ランチョンセミナー 6（第 2 会場：仙台国際センター・会議棟

2F

橘，12：00〜13：00）

新しい超音波ツールによる胎児観察の深化
共催：GE ヘルスケア・ジャパン株式会社
座長：福島県立医科大学

藤 森

敬 也

演者：昭和大学

市 塚

清 健

ランチョンセミナー 7（第 3 会場：仙台国際センター・会議棟

2F

萩，12：00〜13：00）

女性下部尿路症状（FLUTS）と経腟手術
共催：アステラス製薬株式会社
座長：大阪市立大学

古 山

将 康

演者：四谷メディカルキューブ

嘉 村

康 邦

ランチョンセミナー 8（第 4 会場：仙台国際センター・会議棟

2F

桜 1，12：00〜13：00）

Principles of Nuclear and Cytoplasmic Replacement in Human Oocytes
共催：エア・ブラウン株式会社/ブラウンテクノロジーズ株式会社
座長：東北大学

立 花

眞 仁

演者：Center for Embryonic Cell and Gene Therapy, Oregon
Health ＆ Science University, USA

Shoukhrat Mitalipov

ランチョンセミナー 9（第 5 会場：仙台国際センター・会議棟

2F

桜 2，12：00〜13：00）

子宮内膜症・子宮腺筋症の画像診断〜エコーから MRI まで〜
共催：持田製薬株式会社
座長：京都府立医科大学

北 脇

城

演者：倉敷平成病院

太 田

郁 子

― 66 ―

（第 6 会場：仙台国際センター・会議棟

3F

白橿 1，12：00〜13：00）

11

産科大出血の管理 基本と応用
共催：科研製薬株式会社
座長：三重大学

池 田

智 明

演者：京都大学

近 藤

英 治

ランチョンセミナー 11（第 9，10 会場：仙台国際センター・会議棟

1F

小会議室 1，
2，12：00〜13：00）

AMH 検査をいかにいかすか？〜AMH 検査の進歩と不妊だけでなく産婦人科医として必要な基礎知識〜
共催：ロシュ・ダイアグノスティックス株式会社
座長：東京都立墨東病院

久 具

宏 司

演者：浅田レディースクリニック

浅 田

義 正

ランチョンセミナー 12（第 11 会場：仙台国際センター・会議棟

1F

研修室 AB，12：00〜13：00）

婦人科悪性軟部腫瘍の薬物療法トピックス
共催：ノバルティス ファーマ株式会社
座長：岩手医科大学

杉 山

徹

演者：兵庫県立がんセンター腫瘍内科

松 本

光 史

ランチョンセミナー 13（第 12 会場：仙台国際センター・展示棟

会議室 1，12：00〜13：00）

最新機器を用いた婦人科内視鏡下手術―良性疾患から悪性疾患まで―
共催：カールストルツ・エンドスコピー・ジャパン株式会社/エム・シー・メディカル株式会社
座長：東北大学

新 倉仁

演者：慶應義塾大学

升 田

博 隆

慶應義塾大学片 岡

史 夫― 67 ―

日㈮プログラム

ランチョンセミナー 10

日㈮
プログラム
11

ランチョンセミナー 14（第 13 会場：仙台国際センター・展示棟

会議室 2，12：00〜13：00）

先天性サイトメガロウイルス感染症の診断と治療の展望
共催：株式会社シノテスト
座長：神戸大学

山 田

秀 人

演者：日本大学小児科

森 岡

一 朗

ランチョンセミナー 15（第 14 会場：仙台国際センター・展示棟

会議室 3，12：00〜13：00）

胎児心拍数モニタリング 現在・過去・未来
共催：アトムメディカル株式会社
座長：宮崎大学

鮫 島浩

演者：東北大学

木 村

芳 孝

ランチョンセミナー 16（第 15 会場：仙台国際センター・展示棟

会議室 4，12：00〜13：00）

悪性軟部腫瘍に対する化学療法
共催：大鵬薬品工業株式会社
座長：京都医療センター

小 西

郁 生

原 野

謙 一

演者：国立がん研究センター東病院乳腺・腫瘍内科

ランチョンセミナー 17（第 17 会場：東北大学百周年記念会館

2F

川内萩ホール，12：00〜13：00）

婦人科腫瘍におけるゲノム情報―遺伝医療の立場から
共催：アストラゼネカ株式会社
座長：鹿児島大学

小 林

裕 明

演者：札幌医科大学

櫻 井

晃 洋

― 68 ―

（第 18 会場：東北大学百周年記念会館

2F

川内萩ホール

会議室 1，
2，
3，12：00〜13：00）

11

婦人科腫瘍に対する手術の技術とコツの伝承〜再現性の高い手術をめざそう！
共催：コヴィディエンジャパン株式会社
座長：慶應義塾大学

青 木

演者：日本大学

川 名

敬

阪 埜

浩 司

慶應義塾大学大 輔

イブニングセミナー 1（第 4 会場：仙台国際センター・会議棟

2F

桜 1，16：20〜18：20）

女性ヘルスケア最前線〜子宮内膜症の life!
long management におけるホルモン療法の意義を考える〜
共催：バイエル薬品株式会社
座長：東京大学
京都府立医科大学

大須賀

穣

北 脇

城

甲 賀

かをり

小 林

浩

若 槻

明 彦

子宮内膜症の life-long management：LEP 製剤連続投与の意義と実際
演者：東京大学
子宮内膜症による将来の卵巣がんリスクを見据えた治療戦略
演者：奈良県立医科大学
子宮内膜症による将来の心血管疾患リスクを見据えた治療戦略
演者：愛知医科大学

イブニングセミナー 2（第 6 会場：仙台国際センター・会議棟

3F

白橿 1，16：20〜17：20）

婦人科と放射線科の連携による子宮筋腫の動脈塞栓術（UAE）
共催：日本化薬株式会社
座長：倉敷成人病センター

安 藤

正 明

演者：久留米大学

津 田

尚 武

演者：久留米大学放射線科

小金丸

雅 道

治療選択肢のひとつとしての UAE
IVR 医による UAE 治療の実際― 69 ―

日㈮プログラム

ランチョンセミナー 18

日㈮
プログラム
11

イブニングセミナー 3（第 11 会場：仙台国際センター・会議棟

1F

研修室 AB，17：00〜18：20）

思春期への HPV ワクチン接種を再考する
共催：MSD 株式会社
座長：金沢医科大学

笹 川

寿 之

笹 川

寿 之

小 柳

憲 司

必ず知っておきたい HPV 感染症と予防ワクチンの最新知識
演者：金沢医科大学
不定愁訴と子どものこころ〜思春期心身症の治療について
演者：長崎県立こども医療福祉センター― 70 ―

第2日

日㈮
プログラム

JSOG Congress Award Candidate

11

5 月 11 日（金）第 6 会場

仙台国際センター・会議棟 3F：白橿 1
8：20〜9：20

Group 1 Award 1 Reproduction
Chair：TAOG, Taiwan

Tsung-Cheng Kuo

Yamaguchi University Norihiro Sugino
IS―AC―1― 1. Uterine progesterone signaling is a mechanistic target for metformin therapy inpolycystic ovary syndrome
Linus R Shao（The Sahlgrenska Academy at the University of Gothenburg,
Sweden）et al.

IS―AC―1― 2. Quantification of primordial follicle using optical coherence tomography intended
for investigating effective ovarian tissue transplantation
Seido Takae（St. Marianna University School of Medicine）et al.

IS―AC―1― 3. The PGC!1α!mediated pathway as a potential therapeutic target in endometriosis
Hisashi Kataoka（Kyoto Prefectural University of Medicine）et al.

IS―AC―1― 4. HSD3B1 and Androgenetic alopecia in polycystic ovarian syndrome women
Yi-An Tu（National Taiwan University Hospital, Taiwan）et al.

第2日

5 月 11 日（金）第 12 会場

仙台国際センター・展示棟：会議室 1
8：20〜9：20

Group 2 Award 2 Oncology 1
Chair：KSOG, Korea Eung Soo Lee
Niigata University

Takayuki Enomoto

IS―AC―2― 1. Clinical outcomes and risk of recurrence among patients with vaginal
intraepithelial neoplasia
Mi-Kyung Kim（Ewha Womans University of Korea, Korea）et al.

IS―AC―2― 2. Acceptability and thoughts about Multipurpose Human Papillomavirus Vaccines
in Korean physicians and mothers of Adolescent Girls：What to consider whenintroducing a new vaccine
Hyewon Seo（Catholic University of Korea, Korea）et al.

IS―AC―2― 3. Contribution of T helper 17 in peripheral blood to expression of PD!L1 in ovariancancerAeri Aotsuka（The University of Tokyo Hospital）et al.

― 71 ―

IS―AC―2― 4. Microsatellite instability is a potential biomarker for immune checkpoint inhibitor

日㈮
プログラム

（anti PD!1/PD!L1 antibody）in endometrial cancer
Hitomi Yamashita（Shimane University）et al.

11

第2日

5 月 11 日（金）第 13 会場

仙台国際センター・展示棟：会議室 2
8：20〜9：20

Group 3 Award 3 Oncology 2/Womenʼs health care
Chair：KSOG, Korea Seung-Cheol Kim
University of Occupational and Environmental Health Toru Hachisuga
IS―AC―3― 1. Nationwide cohort study of the risk of major adverse cerebrovascular andcardiovascular events in the Asian women with endometriosis
Hsin-Ju Chiang（Kaohsiung Chang Gung Memorial Hospital, Taiwan）et al.

IS―AC―3― 2. Mediator complex subunit 1（MED1）is a novel binding partner of BRCA1 andregulates homologous recombination repair
Harunori Honjoh（The University of Tokyo）et al.

IS―AC―3― 3. Lack of interval cytoreductive surgery after neoadjuvant chemotherapy inperitoneal, ovarian, or fallopian tube cancer：a description of reasons andtreatment outcomes
Myong Cheol Lim（National Cancer Center（NCC）, Korea）et al.

IS―AC―3― 4. Differential localization of extracellular matrix related proteins in the uterine
cervix of female pelvic organ prolapse
Aki Takase（Osaka City University）et al.

第2日

5 月 11 日（金）第 14 会場

仙台国際センター・展示棟：会議室 3
8：20〜9：20

Group 4 Award 4 Perinatology 1
Chair：ACOG, USA Thomas M. Gellhaus
Kitasato University Nobuya Unno
IS―AC―4― 1. The discovery of new biomarkers for preterm birth prediction
Hyun Joo Shin
（Ewha Womans University Medical School, Korea）et al.

IS―AC―4― 2. Comparison of pregnancy outcome among nulliparas with and without
microalbuminuria at the end of the second trimester
Maryam Kashanian（Iran University of Medical Sciences, Iran）et al.

IS―AC―4― 3. Causes and risk factors for singleton stillbirth in Japan：an analysis using theJapan Society of Obstetrics and Gynecology Perinatal Database, 2013!2014
Rei Haruyama（The University of Tokyo）et al.

― 72 ―

IS―AC―4― 4. Risk factors for congenital cytomegalovirus infection in pregnant women with
Akiko Uchida（Kobe University Hospital）et al.

第2日

5 月 11 日（金）第 15 会場

仙台国際センター・展示棟：会議室 4
8：20〜9：20

Group 5 Award 5 Perinatology 2
Chair：ACOG, USA Haywood L. Brown
Hiroshima University Yoshiki Kudo
IS―AC―5― 1. Pre!pregnancy factors associated with development of hypertension in womenwith preeclampsia
Hye Jin Choi（Korea University, Korea）et al.

IS―AC―5― 2. Antenatal ultrasound findings and hemorrhagic outcomes in suspected
abnormally invasive placenta
Su Kyeong Kong
（Gil Medical Center Gachon University, Korea）et al.

IS―AC―5― 3. Obstetric outcome and use of medications during pregnancy with systemic lupus
erythematosus, rheumatoid arthritis and inflammatory bowel disease in Japan；Anationwide retrospective descriptive study
Sayaka Tsuda（University of Toyama）et al.

IS―AC―5― 4. Antenatal anti!arrhythmic treatment for fetal tachyarrhythmias：a prospective
multicenter trial in Japan
Takekazu Miyoshi（National Cerebral and Cardiovascular Center）et al.

― 73 ―

日㈮プログラム

non!primary infection

11

日㈮
プログラム

J-K-T Young Doctors Session

11

第2日

5 月 11 日（金）第 5 会場

仙台国際センター・会議棟 2F：桜 2
8：08〜9：20

Chair：TAOG, Taiwan

Hong-Nerng Ho

JSOG Noriaki Sakuragi
JKT―YD― 1. The prognostic role of pre!
treatment complete blood count profiling in earlycervical cancer
Joseph J. Noh（Samsung Medical Center, Sungkyunkwan University School of
Medicine, Korea）et al.

JKT―YD― 2. Clinical significance of p53!binding protein 1 nuclear foci in cervical squamous
intraepithelial lesions
Sayaka Kawashita（Nagasaki University）et al.

JKT―YD― 3. The expression of glucagon!
like peptide!1 receptor could be a novel biomarker ofendometrial cancer possibly by stimulating autophagy via AMPK signaling
pathway
Ranka Kanda（Teikyo University）et al.

JKT―YD― 4. The clinical prognostic correlation of CypB in epithelial ovarian carcinoma
patients
Heng-Cheng Hsu（National Taiwan University Hospital Hsin!
Chu Branch,Taiwan）et al.

JKT―YD― 5. Laparoscopic cornuostomy versus cornual resection using hemostatic suture：interstitial ectopic pregnancy
Bo Ram Yu（Chonbuk National University of Korea, Korea）et al.

JKT―YD― 6. Porphyromonas gingivalis !lipopolysaccharide enhances inflammation in amniotic
mesenchymal cells
Haruhisa Konishi（Hiroshima University）et al.

JKT―YD― 7. Comparisons of the effects of estradiol valerate and medroxyprogesterone acetate
versus tibolone on menopausal symptoms, lower urinary tract symptoms andfemale sexual function：A preliminary report
Pei-Ling Chen（Far Eastern Memorial Hospital, Taiwan）et al.

JKT―YD― 8. The effectiveness of laparoscopic ultrasonography during LM operation to reduce
residual myomas
Mamoru Shigeta（Kindai University Hospital）et al.

― 74 ―

第2日

日㈮
プログラム

International Session Poster

11

5 月 11 日（金）ポスター会場①

仙台国際センター・展示棟：展示室
10：30〜11：10

Group 1 Cervical cancer/CIN/SIL 1
Chair：Iwate Medical University Hiroaki Itamochi
ISP―1―

1.

Compare the levels of IL!2, IL!6, IL!10 and IFN!
γ in cervical lesions tissues andserum of Uyghur and Han women
Mayinuer Niyazi（The Peopleʼs Hospital of Xinjiang Uighur Autonomous Region,
China）et al.

ISP―1―

2.

Selective cytotoxic effect of non!
thermal micro!
DBD plasma

ISP―1―

3.

Whole!genome analysis of human papillomavirus genotypes 52 and 58 isolated

Byung Su Kwon
（Pusan National University Hospital, Korea）et al.

from Japanese women with cervical intraepithelial neoplasia and invasive cervicalcancerYuri Tenjimbayashi（Showa University）et al.

ISP―1―

4.

Mieap induces cell death via non!canonical mitophagy in human cervical cancer

ISP―1―

5.

Establishment of a patient!derived orthotopic Xenograft（PDOX）model of HER!2!

Makoto Yamamoto（University of Fukui）et al.

positive cervical cancer expressing the clinical metastatic pattern
Takuya Murata（Kawasaki Medical School）et al.

ISP―1―

6.

CDX2 expression and cancer progression in cervical cancer

ISP―1―

7.

Tumor!derived G!CSF induces Tumor!
associated neutrophils（TANs）andSuguru Nosaka（Hiroshima University）et al.

suppresses the activation of T cell in cervical cancer microenvironment
Naoko Komura（Osaka University）et al.

ISP―1―

8.

The clinicopathological characteristics and PD!L1 expression in neuroendocrine
carcinoma of the cervix
Yukihiro Hirata（The Jikei University Kashiwa Hospital）et al.

17：00〜17：40

Group 2 Cervical cancer/CIN/SIL 2
Chair：Dokkyo Medical University Saitama Medical Center Satoshi Takakura
ISP―2―

1.

Research on early warning factors of cervical carcinomas and precancerous
lesions
Suray Husayin（The Peopleʼs Hospital of Xinjiang Uighur Autonomous Region,
China）et al.

― 75 ―

ISP―2―

日㈮
プログラム
11

2.

A neast case!
control study on type!specifice persistent HPV infection in Uyghur
women
Gulan Tuohetimulati（The Peopleʼs Hospital of Xinjiang Uighur Autonomous
Region, China）et al.

ISP―2―

3.

Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel
and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients
Hiroko Shimura（Osaka University）et al.

ISP―2―

4.

Phase I study of multiple epitope peptide vaccination in patients with recurrent or
persistent cervical cancer
Yuji Ikeda（Saitama Medical University International Medical Center）et al.

ISP―2―

5.

Neoadjuvant intraarterial chemotherapy using an original four!
lumen double!
balloon catheter for locally advanced uterine cervical cancer
Tomohito Tanaka（Osaka Medical College）et al.

ISP―2―

6.

Comparison of adjuvant therapy for node!positive clinical stage IB!
IIB cervicalcancer：systemic chemotherapy versus pelvic irradiation
Hideki Tokunaga（Tohoku University）et al.

ISP―2―

7.

Effectiveness of adjuvant systemic chemotherapy for intermediate!
risk stage IB
cervical cancer
Takamichi Minato（Tohoku University Hospital）et al.

ISP―2―

8.

Paclitaxel plus cisplatin as adjuvant chemotherapy after radical hysterectomy forintermediate!and high!risk stage IB!IIB cervical cancer
Yuta Inoue（Osaka City University）et al.

ISP―2―

9.

The comparison of CCRT protocols composed of different chemotherapy regimens
for the patients with locally advanced cervical squamous cell carcinoma
Yoshifumi Nakao（Saga University）et al.

10：30〜11：10

Group 3 Cervical cancer/CIN/SIL 3
Chair：Osaka City University Toshiyuki Sumi
ISP―3―

1.

Posttreatemt HPV genotyping for recurrent high grade cervical intraepithelial
neoplasias
Chan Joo Kim（St. Paulʼs Hospital, The Catholic University of Korea, Korea）et al.

ISP―3―

2.

HPV subtyping according to the tissue biopsy of the cervix of the uterine at an
institution
Eunseop Song
（Inha University of Korea, Korea）et al.

ISP―3―

3.

Outcomes of patients diagnosed with atypical glandular cells（AGC）in a single!
institution experience
Mie Tanaka（Osaka University）et al.

ISP―3―

4.

The pathological investigation of parametrial invasion to diminish type III radical
hysterectomy for stage IB!
IIA cervical cancers
Fuminori Ito（Nara Prefecture General Medical Center）et al.

― 76 ―

ISP―3―

5.

Lymph node metastasis of stage IA1 uterine cervical squamous cell carcinoma：
Kana Sekigawa（Shin!
yurigaoka General Hospital）et al.

ISP―3―

6.

Leukocytosis as an initial sign of aggressive growth of granulocyte colony!
stimulating factor!producing cervical cancer
Ai Yoshida（Kobe Medical Center）et al.

ISP―3―

7.

Retrospective study of metastatic size and recurrence pattern for lymph node
positive cervical cancer patients
Tomoyuki Nagai（Tohoku University Hospital）et al.

ISP―3―

8.

Squamous cell carcinoma of the cervix with superficial spreading to theendometrium：A case report
Shuhei Abe（Nagasaki University）et al.

ISP―3―

9.

Usefulness of diffusion!
weighted MRI（DW!
MRI）in the detection of lymph nodemetastases in patients with uterine cervical cancer
Yoshinori Takeda（Nara Prefecture General Medical Center）et al.

ISP―3― 10.

Clinical Features of High!grade Neuroendocrine Carcinoma of the Uterine
Cervix：a single institute retrospective review of 21 cases
Yoko Furutake（Kyoto University）et al.

17：00〜17：40

Group 4 Endometrial cancer 1
Chair：Toho University Ohashi Medical Center Kaneyuki Kubushiro
ISP―4―

1.

Decreased expression of nuclear receptor coactivator!6 may correlate with theprogression and less differentiation of human endometrioid adenocarcinoma
Norikazu Watanabe（Yamagata University Hospital）et al.

ISP―4―

2.

Estrogen!related receptor α induces epithelial!
mesenchymal transition throughthe cancer!stromal interaction in endometrial cancer
Kaori Yoriki（Kyoto Prefectural University of Medicine）et al.

ISP―4―

3.

There is a possibility that DUSP6 contributes to one of the stem!like cell
phenotypes in uterine endometrial cancer
Masaya Kato
（Kyushu University）et al.

ISP―4―

4.

The high expression of claudin!
6 is a poor prognostic factor in uterine endometrial
cancerManabu Kojima（Fukushima Medical University Hospital）et al.

ISP―4―

5.

Characterization of a cell line（NOMH!
2）originating from a human uterine serous
carcinoma
Takashi Yamada（Osaka Medical College）

ISP―4―

6.

The usefulness of transcervical needle biopsy in uterine body tumors
Shunpei Kato
（Hiroshima University Hospital）et al.

― 77 ―

日㈮プログラム

case report1110：30〜11：10

日㈮
プログラム
11

Group 5 Endometrial cancer 2
Chair：Dokkyo Medical University Kiyoshi Hasegawa
ISP―5―

1.

Survival analyses based on tumor microenvironment profile in endometrial
carcinoma
Shuang Zhang（University of Tsukuba）et al.

ISP―5―

2.

Nanopore sequencing to uncover complex isoforms indicating lymph!node
metastasis for endometrial cancer patients
Yosuke Ito（Juntendo University Hospital）et al.

ISP―5―

3.

Dysadherin regulates cell invasion and might be an independent prognostic factor
in uterine endometrial cancer
Kyoko Akashi（Kyoto Prefectural University of Medicine）et al.

ISP―5―

4.

The role of myeloid!
derived suppressor cells（MDSC）in the induction ofendometrial cancer stem cells（CSC）
Eriko Yokoi（Osaka University）et al.

ISP―5―

5.

Over expression of Carbonyl reductase 1 induces MET by suppressing
transforming growth factor!beta signaling in uterine leiomyosarcoma cells
Takuya Kajimura（Yamaguchi University）et al.

ISP―5―

6.

Prolactin contributes to the cell proliferation of type 1 endometrial cancer by theregulation of prolactin receptor and estrogen receptor via MAPK signaling
pathway
Erdenebaatar Chimeddulam（Kumamoto University）et al.

ISP―5―

7.

Genetic and epigenetic characterization of young!
onset endometrial cancer
Takeshi Makabe（Keio University）et al.

17：00〜17：40

Group 6 Ovarian/Tubal/Peritoneal cancer 1
Chair：Teikyo University Chiba Medical Center
ISP―6―

1.

Shan-Guang Liang

A long non!coding RNA LUCAT1 mediates taxane!resistance acquisition in
ovarian cancer
Satoshi Tamauchi（Nagoya University）et al.

ISP―6―2.

CXCL10 works as a tumor promoter in tumor microenvironment in ovarian cancer

ISP―6―3.

CXCL17, as a key regulator of microenvironment, promotes peritoneal

Juri Ogishima（The University of Tokyo）et al.

dissemination in ovarian cancer
Akira Kawata（The University of Tokyo）et al.

ISP―6―

4.

Antisense oligo nucleotide of Annexin A4 improves platinum resistance in ovarian
clear cell carcinoma
Reisa Kakubari（Osaka University）et al.

― 78 ―

ISP―6―

5.

Histone methyltransferases are the candidate therapeutic targets in high!grade
Asako Kukita（The University of Tokyo）et al.

ISP―6―

6.

Clinicopathological characteristics of clear cell ovarian carcinomas without any
mutations in ARID1A and PIK3CA
Akira Nishijima（The University of Tokyo）et al.

ISP―6―

7.

Ultrasound!based logistic regression model LR2 versus magnetic resonanceimaging for discriminating between benign and malignant adnexal masses：aprospective study
Kanae Shimada（Showa University）et al.

ISP―6―

8.

Combination of MDM2 inhibitor, DS!3032b, and mTOR inhibitor, everolimus,
exerts antitumor effect in ovarian and renal clear cell carcinomas
Yoshiko Kawata（The University of Tokyo）et al.

ISP―6―

9.

The impact of UGT1A1 genotype upon prognoses of the patients with ovarian
clear cell carcinomas!a historically controlled study!
Masashi Takano（Department of Tumor Chemotherapy, National Defense
Medical College Hospital）et al.

10：30〜11：10

Group 7 Ovarian/Tubal/Peritoneal cancer 2
Chair：The Jikei University Daisan Hospital
ISP―7―

1.

Seiji Isonishi

CRISPR/Cas9!
mediated genome editing and efficient PD!
L1 disruption on tumor
cells promote antitumor immunity and suppress ovarian cancer progression in amouse model
Tamaki Yahata（Wakayama Medical University）et al.

ISP―7―

2.

Exosomal miR!99a!5p is upregulated in ovarian cancer patientsʼ sera and enhance
PAI!1 expression in neighboring peritoneal mesothelial cells to facilitate cancer
invasion
Akihiko Yoshimura（Osaka University）et al.

ISP―7―

3.

Induction of anti!VEGF therapy resistance by upregulated expression of
microseminoprotein（MSMP）
Takashi Mitamura（Hokkaido University Hospital）

ISP―7―

4.

Genomic alterations of tumor!
related pathways suppresses a mitochondrial
function through the activation of PDK2 in ovarian clear cell carcinoma
Sachiko Kitamura（Kyoto University）et al.

ISP―7―

5.

Role of RNA chaperones in ovarian cancer metastasis

ISP―7―

6.

CD141+ Dendritic cells in ovarian cancer microenvironment

ISP―7―

7.

A Machine Learning Algorithm Using Blood Biomarkers for Diagnostic and

Mahy Egiz（Tohoku University）et al.
Rin Mizuno（Kyoto University）et al.

Prognostic Prediction in Epithelial Ovarian Cancer
Junya Tabata（The Jikei University School of Medicine）et al.

― 79 ―

日㈮プログラム

serous ovarian carcinoma（HGSC）

11

ISP―7―8.

Diagnosis of early stage ovarian clear cell carcinoma（CCC）and endometrioid

日㈮
プログラム

carcinoma（EMC）!the combination assay of A2160（Alpha!chain of Complement
4!Binding Protein with Fully!Sialylated Glycans）and C4BP with all types ofglycans（ALL!C4BP）!

11

Masaru Hayashi（Tokai University Hospital）et al.

ISP―7―

9.

Ex vivo chemosensitivity assay using patient!derived spheroids of ovarian cancer
Yu Ito（Osaka University）et al.

17：00〜17：40

Group 8 Ovarian/Tubal/Peritoneal cancer 3
Chair：Cancer Institute Ariake Hospital Nobuhiro Takeshima
ISP―8―

1.

Lysosomal function estimated through the autophagic features in ovariancarcinoma
Koji Kumagai（Osaka Railway Hospital）et al.

ISP―8―

2.

Overexpression of histone methyltransferases is involved in the proliferation ofovarian clear cell carcinomas
Machiko Kojima（The University of Tokyo Hospital）et al.

ISP―8―

3.

The mechanism of ceramide nanoliposomes!induced necroptosis in ovarian cancer

ISP―8―

4.

GEP oncogene induces epithelial!mesenchymal transition through LATS1 down!

Xuewei Zhang（Tohoku University）et al.

regulation in ovarian cancer
Hiroshi Yagi（Kyushu University）et al.

ISP―8―

5.

Regulation of Reg IV expression and prediction of response to 5!
fluorouracil by
CDX2 in ovarian mucinous carcinoma
Iemasa Koh（Hiroshima University）et al.

ISP―8―

6.

Expression of epithelial cell adhesion molecule and CD44 variant 6 is a predictive
biomarker of chemoresistance and prognosis in epithelial ovarian cancer
Yashiro Motooka（Kumamoto University）et al.

ISP―8―

7.

Ferroptosis induced by erastin in RAS mutant ovarian cancer cells

ISP―8―

8.

Efficacy and toxicity of PEGylated liposomal doxorubicin for recurrent ovarian

Motoki Takenaka（Gifu University Hospital）et al.

cancer according to number of previous chemotherapy regimens：Comparison
with gemcitabine
Yoshifumi Takahashi（Jichi Medical University）et al.

ISP―8―

9.

Interleukin!34 is a promising prognostic biomarker in ovarian cancers
Hiraku Endo（St. Marianna University School of Medicine）et al.

10：30〜11：10

Group 9 Other malignant or benign tumor 1
Chair：Toho University Sakura Medical Center Toshihiko Kinoshita
ISP―9―1.

SPIO method for the diagnosis of pelvic lymph node metastasis
Kosuke Murakami（Kindai University）et al.

― 80 ―

ISP―9―2.

Discrimination of malignant transformation from benign endometriosis using
Yuki Yamada（Nara Medical University）et al.

ISP―9―

3.

Pathogenic KRAS mutation was frequently found in endometrial polyp withwhole exome sequencing
Takashi Takeda（Keio University）et al.

ISP―9―

4.

Evaluation of safety and diagnostic concordance for flexible hysteroscopy in 1,591
outpatient cases
Kosuke Tsuji（Keio University）et al.

ISP―9―

5.

Influence of adverse effects on quality of life of survivors of gynecologic cancer

ISP―9―

6.

Application of hysteroscopic transcervical resection for cervical proliferative

Keiichiro Nakamura（Okayama University）et al.

disorder diagnostic method
Kensuke Hamamura（Juntendo University Nerima Hospital）et al.

ISP―9―

7.

Relation between intracardiac thrombus and advanced cancer：Report of two
cases
Yasuka Miyakuni（Juntendo University Urayasu Hospital）et al.

ISP―9―

8.

Consideration of outpatient mammary gland at our hospital

ISP―9―

9.

A retrospective study for the effectiveness and the safety of chemotherapy for

Takako Kawakita（Tokushima University）et al.

elderly gynecologic cancer patients
Mihoko Aoki
（Yokohama City University Hospital）et al.

17：00〜17：40

Group 10 Trophoblastic disease
Chair：Kitasato University Takashi Onda
ISP―10― 1. Primary vaginal gestational trophoblastic neoplasia treated with uterine
angiographic embolization and chemotherapy
Maria Concepcion Cenizal（St. Lukeʼs Medical Center, Philippines）et al.

ISP―10― 2. The Mole that Created a Hole：A Case of an Invasive Mole with Uterine
Perforation in a Primigravid
Lugie Testado-Ouano（Manila Central University!
Ultrasound Services
Incorporated, Philippines）et al.

ISP―10― 3. Prognostic effect of ABO blood groups in patients with androgenetic complete
hydatidiform moles
Asuka Sato
（Chiba University）et al.

ISP―10― 4. Primary choriocarcinoma of the mesentery in a pregnancy woman：A case report
Misaki Ozawa（Yokohama City University Medical Center）et al.

ISP―10― 5. Treatment of choriocarcinoma with 4!day methotrexate, etoposide andactinomycin D regimen：a single center experience
Eiko Yamamoto（Department of Medical Adminst, Nagoya University）et al.

― 81 ―日㈮プログラム

near!infrared approach11

ISP―10― 6. The Usefulness of genetic analysis for differential diagnosis between complete and

日㈮
プログラム
11

partial hydatidiform moles
Noriko Miyashita（Nagasaki University）et al.

ISP―10― 7. Three cases of complete hydatidiform mole coexistent with a live twin fetus
Hikari Yoshizawa（Kobe University）et al.

10：30〜11：10

Group 11 Perinatal care 1
Chair：Tohoku University Masatoshi Saito
ISP―11― 1. The change of maternal cardiac function in twin pregnant women
Mayu Ukai（TOYOTA Memorial Hospital）et al.

ISP―11― 2. Pregnancy outcomes of MD twins
Miki Nishizawa（Teikyo University）et al.

ISP―11― 3. Clinical significance of pregnancy in Japanese women aged 15 years
Asako Watanabe（Japanese Red Cross Katsushika Maternity Hospital）et al.

ISP―11― 4. Pregnancy after fertility preservation with high!dose medroxyprogesterone
acetate：Three cases of obstetric complications
Karin Imaizumi（Fukushima Medical University）et al.

ISP―11― 5. Pregnancy outcome of extremely advanced maternal age
Tomoyuki Sekizuka（Niigata University Medical and Dental Hospital）et al.

ISP―11― 6. Ultrasound study of fetal movements in singleton and twin pregnancies at 12 to 19
weeks
Mohamed Aboellail（Kagawa University）et al.

ISP―11― 7. The effect of trimester!specific gestational weight gain on the risk of light for datein Japanese women stratified by the methods to calculate trimester!
specificgestational weight gain
Takuhiro Yamada（Aiwa Hospital）et al.

ISP―11― 8. The clientʼs attitude survey after invasive or non!invasive prenatal testing
Mie Tahara（Osaka City General Hospital）et al.

ISP―11― 9. An investigation of the benefits of first trimester ultrasound screening combinedwith second trimester maternal serum screening
Yumi Araki（Hiroshima University）et al.

17：00〜17：40

Group 12 Fetal complication 1
Chair：Teikyo University Eiji Ryo
ISP―12― 1. Immunoglobulin fetal therapy for symptomatic congenital cytomegalovirus
infection
Yutoku Shi（Kobe University）et al.

ISP―12― 2. Anti!cytomegalovirus IgM titer for congenital infection in first!
trimester
pregnancy with primary infection
Kuniaki Toriyabe（Mie University Hospital）et al.

― 82 ―

ISP―12― 3. Biphasic MCA!PSV elevation in a case of congenital cytomegalovirus infection

Junya Sakuma（Toho University Omori Medical Center）et al.

ISP―12― 5. Measuring fetal lung volume through fetal MRI imaging prior to ex utero
intrapartum treatment（EXIT）for fetal airway occlusion and stenosis could
contribute to EXIT success：a retrospective multicenter joint study
Satoshi Dohi（Showa University Northern Yokohama Hospital）et al.

ISP―12― 6. Prediction of the severity of lung hypoplasia in congenital diaphragmatic hernia
Yuka Yamamoto（Juntendo University Urayasu Hospital）et al.

ISP―12― 7. A case of prenatal diagnosis of congenital hiatal hernia
Moe Yorozu（Okayama Medical Center）et al.

ISP―12― 8. A case of fetal megalocystis and oligohydramnios with bladder size reduction andamniotic fluid volume improvement during the second trimester
Eriko Iwane（Tokyo Womenʼs Medical University Yachiyo Medical Center）et al.

ISP―12― 9. Familial campomelic dysplasia due to maternal germinal mosaicism
Daisuke Higeta（Gunma University Hospital）et al.

ISP―12― 10. 14 cases of fetal skeletal dysplasia：accuracy of prenatal diagnosis
Miyoko Waratani（Kyoto Prefectural University of Medicine）et al.

10：30〜11：10

Group 13 Preterm labor 1
Chair：Jichi Medical University

Akihide Ohkuchi

ISP―13― 1. Repairing fetal membranes using elastomeric sealant in vivo mouse model
Yosuke Kawamura（Kyoto University）et al.

ISP―13― 2. An ex vivo model and case report using intracervical elastomeric sealant forpreviable spontaneous premature rupture of the membranes
Eiji Kondoh（Kyoto University）et al.

ISP―13― 3. Development of a prognostic/diagnostic examination system of preterm birth,targeting serum galectin!3
Satoshi Urabe（Hiroshima University）et al.

ISP―13― 4. Analysis of bacterial floral profile of the amniotic fluid in the cases of intra!
amniotic inflammation using next generation sequencer
Tsuyoshi Yamasaki（Kyushu Medical Center）et al.

ISP―13― 5. Risk factors for preterm birth in ureaplasma!infected pregnant women withpreterm labor
Erina Hashimoto（Nihon University Itabashi Hospital）et al.

ISP―13― 6. The association of progranulin level controlled by progesterone with cervicalmaturation
Taiki Samejima（The University of Tokyo Hospital）et al.

― 83 ―日㈮プログラム

Sho Tano（Perinatal Medical Center, TOYOTA Memorial Hospital）et al.

ISP―12― 4. Prediction of functional pulmonary hypoplasia using MRI

11

17：00〜17：40

日㈮
プログラム
11

Group 14 HDP 1
Chair：Tokai University Hitoshi Ishimoto
ISP―14― 1. Time!
series Analysis of Life!logs to Predict Hypertensive Disorders of Pregnancy
in Maternity Log Study
Takafumi Yamauchi（NTT DOCOMO, INC./Tohoku University）et al.

ISP―14― 2. Prediction of Hypertensive Disorders of Pregnancy by Using Genetic Informationin Maternity Log Study
Yoshiki Tsunemoto（NTT DOCOMO, INC.）et al.

ISP―14― 3. Characteristic changes of the circadian rhythm by ambulatory blood pressure
monitoring seen in preeclamptic women
Yoshikatsu Suzuki（Aichi Medical University）et al.

ISP―14― 4. Cardiac dysfunction in patients with preeclampsia
Eiji Yoshida（Perinatal Medical Center, TOYOTA Memorial Hospital）et al.

ISP―14― 5. Maternal cardiac function in patients with preeclampsia compared with normal
pregnant women
Takuma Yamada（TOYOTA Memorial Hospital）et al.

ISP―14― 6. Long!term outcomes of infants delivered between 24 and 34 weeks of gestation in
women with early!onset hypertensive disorders of pregnancies（HDP）
Junsuke Muraoka（Miyazaki Medical Association Hospital）et al.

ISP―14― 7. The difference of the activated prorenin concentration between pregnant womenwith or without hypertensive disorder of pregnancy
Shoko Tamada（Okayama University）et al.

10：30〜11：10

Group 15 Maternal complication 1
Chair：Hamamatsu University School of Medicine Toshiyuki Uchida
ISP―15― 1. Relationship between 50!g glucose challenge test and large for gestational age
infants among pregnant women without gestational diabetes
Dittakarn Boriboonhirunsarn（Siriraj Hospital, Thailand）et al.

ISP―15― 2. Prevalence of false positive 50!g glucose challenge test and relationship withadverse pregnancy outcomes
Auakarn Thananyai（Siriraj Hospital, Thailand）et al.

ISP―15― 3. Determination of an Optimal 50!g Oral Glucose Challenge Test Cutoff Value to
Screen for Gestational Diabetes Mellitus
Sakiko Matsuoka（Aso Iizuka Hospital）et al.

ISP―15― 4. Present condition and problems of gestational diabetes mellitus care in our
prefecture
Naoto Yonetani（Tokushima University）et al.

― 84 ―

ISP―15― 5. Glycemic and metabolic features in gestational diabetes：singleton versus twin
Yohei Akiba（Keio University）et al.

ISP―15― 6. Efficacy of the risk scoring system to triage patients with gestational diabetes
Hiroshi Yamashita（Nagasaki Medical Center）et al.

ISP―15― 7. Epigenetic modifications of well!
controlled gestational diabetes on cord bloodusing genome!wide methylation analysis
Yoshifumi Kasuga（Keio University）et al.

ISP―15― 8. Is the therapeutic intervention during early pregnancy effective in women withgestational diabetes diagnosed before 20 weeksʼ gestation?
Noriko Odani（Nagasaki Medical Center）et al.

ISP―15― 9. Monochorionic diamniotic twin pregnancy complicated by type I diabetes treatedwith SAP therapy for blood sugar control
Miho Kondo（Kyoto Prefectural University of Medicine）et al.

ISP―15― 10. Correlation of early pregnancy body mass index, waist circumference and waist!
to!hip ratio to gestational diabetes mellitus
Kathryn Bautista（Manila Central University, Philippines）et al.

17：00〜17：40

Group 16 Maternal complication 2
Chair：Niigata University

Koichi Takakuwa

ISP―16― 1. The Missing Link：A Case of Hydrops Fetalis in Alpha Thalassemia
Ivy Karen Romero（Manila Central University!
Filemon D. Tanchoco Medical
Foundation Hospital, Philippines）et al.

ISP―16― 2. Clinical characteristics of women developing perinatal venous thromboembolism
under standardized prophylaxis management following JSOG guideline
Misako Kuramochi（The University of Tokyo Hospital）et al.

ISP―16― 3. Preeclampsia in Pregnancies with Systematic Lupus Erythematosus
Hiroyo Meguro（Fukushima Medical University）et al.

ISP―16― 4. Postpartum thrombotic microangiopathy occurring secondary to systemic lupus
erythematosus：a case report
Kenichiro Hirotani（Kyushu University）et al.

ISP―16― 5. A case of treatment!resistant idiopathic thrombocytopenic purpura during
pregnancy
Maki Okada（Yamaguchi University Hospital）et al.

ISP―16― 6. ARDS due to H3N2 Influenza A occurring in the second trimester of pregnancy：
A case report
Yuri Sasaki（Iwate Medical University）et al.

ISP―16― 7. Analysis of pregnant women with syphilis
Hidenori Sasa（National Defense Medical College）et al.

― 85 ―

日㈮プログラム

pregnancies

11

ISP―16― 8. The meaning of Methicillin!resistant Staphylococcus aureus（MRSA）
colonization

日㈮
プログラム
11

in pregnant women；a prospective cohort study
Jumpei Ogura（Toyooka Hospital）et al.

ISP―16― 9. Acute Appendicitis during Pregnancy
Misako Hideshima（Saga University Hospital）et al.

10：30〜11：10

Group 17 Maternal complication 3
Chair：Saitama Medical Center, Saitama Medical University Kazunori Baba
ISP―17― 1. Obstetrical and perinatal outcomes of the chemotherapy in breast and cervicalcancer during pregnancy
Mee Hyang Ko（Gachon University of Korea, Korea）et al.

ISP―17― 2. Successful Heterotopic Pregnancy with Prior Radical Trachelectomy after TCIC
with MTX Treatment
Eun-Jee Whang（Kangnam Sacred Heart Hospital of Hallym University of Korea,
Korea）et al.

ISP―17― 3. Obstetrical prognosis of patients treated by vaginal radical trachelectomy during
pregnancy
Takafumi Kuroda（Sapporo Medical University）et al.

ISP―17― 4. Clinical features and the management of pregnancy!
associated breast cancer：
Retrospective analysis of 8 patients
Tadahi Okada（Sapporo Medical University Hospital）et al.

ISP―17― 5. A case of colorectal cancer during pregnancy
Miho Saito（Tokyo Metropolitan Bokutoh Hospital）et al.

ISP―17― 6. Primary intramedullary spinal cord tumour in pregnancy：A case report
Kyoko Fujii（University of Fukui Hospital）et al.

ISP―17― 7. A pregnancy with adenomyosis：A case report
Ayaka Tachibana（Tokushima University Hospital）et al.

ISP―17― 8. Current circumstance of the care for pregnancy complicated with adult congenital
heart disease at a non!specialized tertiary perinatal center
Hironobu Hyodo（Tokyo Metropolitan Bokutoh Hospital）et al.

ISP―17― 9. Pregnant women with low TSH and normal FT4 in early pregnancy may haverelatively low risk of preterm delivery
Masahiro Shiba（Teikyo University）et al.

17：00〜17：40

Group 18 Abnormal delivery 1
Chair：Osaka Medical College Daisuke Fujita
ISP―18― 1.

In The Nick of Time A perimortem cesarean delivery following pulmonary
congestion and pre!
eclampsia
Adeline Rose T. Escartin（Manila Central University!
FDTMF Hospital,
Philippines）et al.

― 86 ―

ISP―18― 2. Perimortem Cesarean Section（PMCS）!successful maternal resuscitation of out!
Chiyori Sakamoto（Dokkyo Medical University Hospital）et al.

ISP―18― 3. A retrospective cohort analysis of retained products of conception with
vascularity after second!trimester abortion；incidence, outcomes in expectant
management, and characteristic ultrasonographic features leading to future
severe hemorrhage
Naoya Akiba（The University of Tokyo）et al.

ISP―18― 4. The relationship of anesthetic amount with the prolonged second stage of laborand malrotation in labor analgesia
Hitomi Ando（Juntendo University）et al.

ISP―18― 5. Perinatal maternal cases of disturbance of consciousness transferred to our facility
Yoshihiro Kuritani（Rinku General Medical Center）et al.

ISP―18― 6. The challenge to quantify the uterine contraction；usability of handheld muscle
hardness meter（HMH meter）and its clinical application to obstetric bleeding
management
Kenji Imai
（Nagoya University）et al.

ISP―18― 7. For 10 years prospective study：trial of labor after cesarean（TOLAC）versus
repetitive cesarean based on informed choice
Kaname Uno（Perinatal Medical Center, TOYOTA Memorial Hospital）et al.

ISP―18― 8. Induction of labor with metreurynter at or after 39 weeks of gestation in womenwith one previous cesarean delivery increases the likelihood of failed trial of labor
after cesarean delivery
Kento Misawa（Japanese Red Cross Nagoya Daiichi Hospital）et al.

10：30〜11：10

Group 19 Placenta 1
Chair：Juntendo University Urayasu Hospital Koyo Yoshida
ISP―19― 1. Which risk factor is the most useful to predict placenta accreta pre!operatively?：a retrospective study on placenta previa
Hiromitsu Azuma（Nihon University Itabashi Hospital）et al.

ISP―19― 2. The usefulness of preoperative autologous blood donation before caesarean sectionof placenta previa based on SBOE（the surgical blood order equation）
Junki Imaizumi（Tokushima University）et al.

ISP―19― 3. The optimal amount of preoperative autologous blood donation for placenta previa
and low lying placenta
Ayumi Sakai（Center for Maternal, Fetal and Neonatal Medicine, Saitama Medical
University Saitama Medical Center）et al.

ISP―19― 4. Placenta accreta following hysteroscopic lysis of adhesions caused by Ashermanʼs
syndrome
Yuko Sonan（Yokohama City University Medical Center）et al.

― 87 ―

日㈮プログラム

hospital onset cardiopulmonary arrest, a case report11ISP―19― 5. Risk factors for the placenta with velamentous umbilical cord insertion among

日㈮
プログラム
11

term singleton ART pregnancies
Satoshi Furuya（Kubonoya Ob/Gyn Clinic）et al.

ISP―19― 6. The importance of fetal/placental weight ratio for the evaluation of small for dateToshiya Itoh（Hamamatsu University School of Medicine Hospital）et al.

ISP―19― 7. Placental mesenchymal dysplasia with severe fetal growth restriction in one sideof placenta of dichorionic diamniotic twin pregnancy
Shoko Jitsumori（Wakayama Medical University）et al.

ISP―19― 8. A case report of chorioamniotic membrane separation with chorionic hematoma
and inflammation
Kumiko Nakata（Wakayama Medical University Hospital）et al.

17：00〜17：40

Group 20 Technique
Chair：Ehime University Keiichi Matsubara
ISP―20― 1. Practical applications of uterine compression sutures
Jun Takeda（Juntendo University）et al.

ISP―20― 2. Transabdominal Cervical Cerclage via Laparotomy：5 cases
Yuri Hasegawa（Nagasaki University）et al.

ISP―20― 3. Analgesic effect of regular intravenous administration of acetaminophen for pain
due to post!cesarean delivery：a retrospective study
Keiko Yabuzaki（The Jikei University Hospital）et al.

ISP―20― 4. The efficacy of uterine compression suture as a procedure in the management ofprimary atonic bleeding：a historical cohort study
Masaaki Sawada（Osaka University）et al.

ISP―20― 5. Two cases of Vertical Rupture at Side Wall of the Uterine Cervix：Unusual
Clinical Courses and How the Ruptures were Repaired
Yasunori Fukuoka（Takatsuki General Hospital）et al.

ISP―20― 6. The efficacy of a new combined uterine compression suture technique for severe
postpartum hemorrhage
Hasumi Tomita（Tohoku University Hospital）et al.

ISP―20― 7. Usefulness of vertical compression suture for placenta previa in caesarean section
Tomoko Uehara（Tohoku University Hospital）et al.

ISP―20― 8. The experience of CIABO（common iliac artery balloon occlusion）
Shotaro Kai（Kyushu University Hospital）et al.

10：30〜11：10

Group 21 Reproductive physiology/Endocrinology 1
Chair：Toho University Masahiko Nakata
ISP―21― 1. Novel function of a transcription factor WT1 in regulating decidualization inhuman endometrial stromal cells and its molecular mechanism
Isao Tamura（Yamaguchi University）et al.

― 88 ―

ISP―21― 2. Bone morphogenic protein 4（BMP4）is required for establishment of an adequate
Takashi Nagashima（Kyorin University）et al.

ISP―21― 3. Possible Role of Neurotensin and CRH in the Feedback Regulation by Estradiol：
A Study Using Hypothalamic ARC and AVPV Cell Models
Tuvshintugs Tumurbaatar（Shimane University）et al.

ISP―21― 4. 14!3!3 sigma is a novel Basonuclin1!
binding protein in oocyte
Motomasa Ihara（Tohoku University Hospital）et al.

ISP―21― 5. Genome!wide gene expression analysis in mouse granulosa cells undergoingluteinization during ovulation
Yuichiro Shirafuta（Yamaguchi University）et al.

ISP―21― 6. Mitochondria!eating protein is essential for sperm function, but not oocyte quality,
in in vitro fertilization
Makoto Orisaka（University of Fukui）et al.

ISP―21― 7. Identification of the genes associated with endometrial cell aging
Teruhiko Kawamura（Kyushu University）et al.

ISP―21― 8. Forced lipophagy reveals that lipid droplets are required for the development ofpreimplantation embryos in mice
Takayuki Tatsumi（Tokyo Medical and Dental University）et al.

ISP―21― 9. HAND2 regulates IL!15 in human endometrium during progesterone!induced
decidualization
Hiromi Murata（Kansai Medical University）et al.

17：00〜17：40

Group 22 ART 1
Chair：Akita University Yukiyo Kumazawa
ISP―22― 1. New Strategies of preimplantation genetic haplotyping for patients with de novo
mutation and couples with no available DNA samples from family members
Junko Maki（Keio University）et al.

ISP―22― 2. Incidence and predictive factors for complete fertilization failure in in vitro
fertilization treatment cycles：a retrospective cohort study using the assisted
reproductive technology registry of Japan
Toshifumi Takahashi（Fukushima Medical Center for Children and Women
Fukushima Medical University）et al.

ISP―22― 3. Polyunsaturated fatty acid concentration in the human follicular fluid may affectfertilization
Keiko Mekaru（University of the Ryukyus）et al.

ISP―22― 4. Does variable luteal support according to the serum progesterone level at theembryo transfer improve the clinical pregnancy rate of natural frozen!thawed
embryo transfer?
Takuhiko Ichiyama（Saint Mother Hospital）et al.

― 89 ―日㈮プログラム

uterine decidualization and vascularization to support normal pregnancy

11

ISP―22― 5. Egg activation of sperm factor, phospholipase C zeta 1（PLCZ1）as future clinical

日㈮
プログラム
11

applications
Takashi Yamaguchi（Saint Mother Hospital）et al.

ISP―22― 6. An analysis of follicular oxidative stress and oocyte development in ART
treatment cycle
Hiromi Terao（The University of Tokyo）et al.

ISP―22― 7. Progesterone/estradiol ratio as a predictor of obtaining usable blastocyst in
clomiphene IVF cycle
Kenichiro Watanabe（Nippon Medical School）et al.

10：30〜11：10

Group 23 Infertility
Chair：Oita University Yasushi Kawano
ISP―23― 1. Polycystic ovarian morphology in reproductive!
aged Thai women with polycystic
ovary syndrome
Vichuta Unalome（Siriraj Hospital, Mahidol University, Thailand）et al.

ISP―23― 2. The effect of androgen on secondary follicle development might be species!
specificYuya Fujibe（Sapporo Medical University Hospital）et al.

ISP―23― 3. Large uterine myoma with erythropoietin messenger RNA and erythrocytosis
Takafumi Kohama（Keiju Medical Center）

ISP―23― 4. Application of Computer!Aided Sperm Analysis（CASA）for Sperm
Immobilization Test
Yu Wakimoto（The Hospital of Hyogo College of Medicine）et al.

ISP―23― 5. A successful pregnancy in a patient with 46,XY pure gonadal dysgenesis after
transfer of a frozen!thawed embryo derived from donor oocytes
Misato Ukita（The Hospital of Hyogo College of Medicine）et al.

ISP―23― 6. Determining the safe cut!
off point for preimplantation genetic diagnosis（PGD）
ofmitochondrial DNA（mtDNA）disorders
Yuki Mizuguchi（Keio University）et al.

ISP―23― 7. Establishment of female athlete outpatient in our hospital and current problems
for female athlete triad
Sayaka Nose-Ogura（The University of Tokyo Hospital）et al.

ISP―23― 8. What is OHVIRA syndrome? The Müllerian duct anomaly and unilateral renal
agenesis in our 17 cases
Takashi Kuno
（Tohoku University Hospital）et al.

ISP―23― 9. Serum AMH levels in adolescent and young women under 25 years with irregularmenstrual cycles
Akari Watanabe（Nagasaki University Hospital）et al.

― 90 ―

17：00〜17：40

Chair：Tokyo Medical University Naoaki Kuji
ISP―24― 1. Association of eicosapentaenoic acid（EPA）to arachidonic acid（AA）ratio withsecond trimester miscarriage
Nobuko Mimura（The University of Tokyo Hospital）et al.

ISP―24― 2. DomainV of β2GPI has very high affinity with MHC class II
Yuuki Sasagawa（Kobe University）et al.

ISP―24― 3. Reevaluation of the RPL management based on the villus chromosomal analysis
after miscarriage despite previous treatment
Ai Sakamoto（Okayama University）et al.

ISP―24― 4. Induction and clearance of decidual senescent cells in cycling humanendometrium
Yojiro Maruyama（Juntendo University）et al.

ISP―24― 5. The distribution of etiology and therapy outcomes of recurrent pregnancy loss at
our recurrent pregnancy loss clinic
Maho Miyaji（Kobe University Hospital）et al.

ISP―24― 6. Subclinical hypothroidism in women with reccurent pregnancy loss
Kotaro Kubo（Okayama University）et al.

ISP―24― 7. Studies on the outcome of pregnancies which had continued after the
immunosuppressive and anticoagulation therapy for patients with reproductive
failure who are positive for anti!phospholipid antibodies（APLs）
Taro Nonaka（Niigata University Medical and Dental Hospital）et al.

ISP―24― 8. A case of germline mosaicism detected in infertile man with a 47, XYY karyotype
Kentaro Kai（Nakatsu Municipal Hospital）et al.

10：30〜11：10

Group 25 Nutrition/Osteoporosis
Chair：Tokyo Dental College Ichikawa General Hospital

Kiyoshi Takamatsu

ISP―25― 1. The Effects of Five!year Hormone Therapy, Alendronate, Tibolone, andRaloxifene on Bone Mineral Density in Postmenopausal Women（Second Study）
Hoe-Saeng Yang
（Dongguk University of Korea, Korea）et al.

ISP―25― 2. Polysaccharide isolated from Hyuganatsu orange that suppressed rat osteoclast
formation should be an arabinogalactan
Masatoshi Yamaguchi（University of Miyazaki Hospital）et al.

ISP―25― 3. The relation of remaining ovaries and risk of osteopenia：a retrospective study inpatients with ovarian endometrioma
Nana Akino（The University of Tokyo）et al.

ISP―25― 4. A study to evaluate the impact of surgical menopause on bone metabolism inwomen below 50 years of age
Kanae Matsuno（The Jikei University Hospital）et al.

― 91 ―日㈮プログラム

Group 24 Recurrent pregnancy loss

11

ISP―25― 5. Investigation of long!term use of bisphosphonate

日㈮
プログラム

Emi Motegi（Dokkyo Medical University）et al.

ISP―25― 6. Undernourishment in utero programs CIDEA ＆ CIDEC genes expression anddeteriorates hepatic stetatosis：Role of endoplasmic reticulum（ER）stress

11

Jeenat Urmi
（Hamamatsu University School of Medicine）et al.

ISP―25― 7. Metabolomic profiling of prediabetes and diabetes among Japanese
postmenopausal women
Miho Iida（Keio University）et al.

ISP―25― 8. The risk of dyslipidemia after a cystectomy or oophorectomy in endometriosis
Mana Hirano（The University of Tokyo Hospital）et al.

17：00〜17：40

Group 26 Infection
Chair：Showa University Northern Yokohama Hospital Masaaki Nagatsuka
ISP―26― 1. Abdominal palpation with Ou MC manipulation for women with acute abdomen
Ming Cheh Ou（Taipei City Hospital, Taiwan）et al.

ISP―26― 2. Inhibitory Effects of Lactobacillus Culture Supernatants on Candida albicans
Yuko Matsuda（Juntendo University Nerima Hospital）et al.

ISP―26― 3. Successful treatment of Candida glabrata after infectious abortion and maternal
fungemia resulting in the next normal pregnancy
Megumi Oh（Aiiku Hospital）et al.

ISP―26― 4. Abdominal tuberculosis a major cause of infertility in developing countries
Sanjay Chaube（St. Judeʼs Hospital, India）et al.

ISP―26― 5. A case report of pelvic inflammatory disease due to Streptococcus pneumoniae
Miho Ando（Aso Iizuka Hospital）et al.

ISP―26― 6. Human CD134（OX40）
expressed on T cells plays a key role for human herpesvirus
6B replication after umbilical cord blood transplantation
Satoshi Nagamata（Kobe University）et al.

ISP―26― 7. Diagnosis and treatment of the adnexal actinomycosis mimicking an advanced
epithelial ovarian cancer
Seok-Mo Kim（Chonnam National University, Korea）et al.

10：30〜11：10

Group 27 Endometriosis 1
Chair：Juntendo University Mari Kitade
ISP―27― 1. Systemic and local status of myeloid!
derived suppressor cells（MDSC）in
endometriosis patients
Erina Satake（The University of Tokyo）et al.

ISP―27― 2. SR!16234, a novel selective estrogen receptor modulator, for pain symptoms withendometriosis：an open!label clinical trial
Tasuku Harada（Tottori University）et al.

― 92 ―

ISP―27― 3. Expression pattern of membrane proteins in endometrial stromal cells from
Saya Yamashita（Osaka University）et al.

ISP―27― 4. CXCL12!CXCR4 axis is enhanced in endometriosis via prostaglandin E2（PGE2）
Tomoko Makabe（The University of Tokyo）et al.

ISP―27― 5. Bradykinin system is involved in endometriosis!related pain through endothelin!1
production
Osamu Yoshino（University of Toyama）et al.

ISP―27― 6. Dienogest improves decreased chemotaxis of peritoneal natural killer cells fromwomen with endometriosis
Chiaki Izumiya（Kochi Medical School）et al.

17：00〜17：40

Group 28 Uterine leiomyoma 1
Chair：Showa University Kazuhisa Shimodaira
ISP―28― 1. Epidemiology and Recent Treatment of Leiomyomas in Korean Women
Hyejin Hwang（The Catholic University of Korea, Korea）et al.

ISP―28― 2. Disturbed WNT/β!catenin Signaling under Serum Starvation and Hypoxia
Induces Adipocytic Transdifferentiation in Human Uterine Leiomyoma Cells
Hiroshi Harada（University of Occupational and Environmental Health）et al.

ISP―28― 3. Diffuse type adenomyosis is associated with the high incidence of pregnancy
complications
Ayako Hashimoto（The University of Tokyo）et al.

ISP―28― 4. Hypoxia!induced gene expression profile of uterine leiomyoma under
extracellular matrix!
free conditions
Hiroshi Ishikawa（Chiba University）et al.

ISP―28― 5. The use of the apparent diffusion coefficient（ADC）value for differentiating
leiomyosarcoma from leiomyoma variants
Mai Nishimura（Teine Keijinkai Hospital）et al.

10：30〜11：10

Group 29 Surgery 1
Chair：Juntendo University Urayasu Hospital Iwaho Kikuchi
ISP―29― 1. Three cases of retained products of conception treated with hysteroscopic surgery
following uterine artery embolization
Teppei Ichikawa（Dokkyo Medical University Saitama Medical Center）et al.

ISP―29― 2. Laparoscopic Hysterectomy in Large Myoma Uteri by Using Lee!
Huang Point
Mayuko Komori（Toho University Omori Medical Center）et al.

ISP―29― 3. Six ideas to provide accurate histopathological diagnosis for specimens extracted
by power morcellation during total laparoscopic hysterectomy
Yoji Hisamatsu（Kansai Medical University）et al.

― 93 ―

日㈮プログラム

women with endometriosis

11

ISP―29― 4. Spray type adhesion prevention barrier, how to use and short!term report

日㈮
プログラム

Masato Kita
（Kansai Medical University）et al.

ISP―29― 5. Utility of continuous sutures by STRATAFIXⓇ for closing vaginal stump in total
laparoscopic hysterectomy

11

Shintaro Yanazume（Kagoshima University Hospital）et al.

ISP―29― 6. Hand!Assisted In!Bag Morcellation with the Inside Retractor Technique
Yoichi Aoki（Cancer Institute Hospital）et al.

ISP―29― 7. Proper device usage in total laparoscopic hysterectomy：A retrospective analysis
in single instituteKenro Chikazawa（Jichi Medical University Saitama Medical Center）et al.

ISP―29― 8. Contained Morcellation for laparoscopic surgery Using a Tissue Isolation Bag（MorSafe）
Atsuko Yamada（Juntendo University Urayasu Hospital）et al.

ISP―29― 9. Examination of the Efficacy of Combination Therapy with DOAC andFondaparinux in Gynecology Patients with Venous Thromboembolism
Norihito Yoshioka（St. Marianna University School of Medicine）et al.

17：00〜17：40

Group 30 Oncofertility
Chair：Dokkyo Medical University Saitama Medical Center Shuichi Sakamoto
ISP―30― 1. Long!term oncologic and reproductive outcomes of a fertility!
sparingmanagement using high!dose medroxyprogesterone acetate（MPA）for
endometrial adenocarcinoma or atypical endometrial hyperplasia
Emi Yokoyama（Tohoku University Hospital）et al.

ISP―30― 2. Fertility!sparing surgery of malignant transformation arising from mature cystic
teratoma of the ovary
Nobuhisa Yoshikawa（Nagoya University）et al.

ISP―30― 3. A questionnaire study of awareness of the foster care system and adoption for the
young cancer survivor in Japan
Kouhei Sugimoto（Dokkyo Medical University Saitama Medical Center）et al.

ISP―30― 4. Evaluation of fertility preservation in 25 patients with hematologic malignancies
at our hospital
Yuta Kasahara（The Jikei University Hospital）et al.

ISP―30― 5. The best and safest strategy for fertility preservation for cancer patients in Japan
Koichi Kyono（Kyono ART Clinic）et al.

ISP―30― 6. Fertility preservation by ovarian tissue cryopreservation for adolescent andyoung adult patients in our department
Yuta Fujii（Hyogo College of Medicine）et al.

ISP―30― 7. Two cases of the fertility preservation for ovarian malignant tumor to reconfirm
the importance of the oncofertility network
Naoko Kida
（Kansai Medical University）et al.

― 94 ―

ISP―30― 8. A case of retroperitoneal Ewing sarcoma in early pregnancy

Shiho Takeuchi（Tokyo Medical and Dental University）et al.

17：00〜17：40

Group 31 Candidate for Exchange program 1
Chair：Niigata University

Masayuki Sekine

ISP―31― 1. Diagnostic value of bioactive factors from blood sample for the early detection ofuterine sarcoma
Hideaki Tsuyoshi（University of Fukui）et al.

ISP―31― 2. Survival impact of reduction surgery for elderly or obese patients withendometrial cancer
Junko Minato（Tohoku University Hospital）et al.

ISP―31― 3. Introduction of transperitoneal paraaortic lymphadenectomy for endometrial
cancer
Eiji Kobayashi（Osaka University）et al.

ISP―31― 4. Germline BRCA1/2 mutations in patients with epithelial ovarian cancer
Akiko Abe（Tokushima University）et al.

ISP―31― 5. The refractoriness to anti!VEGF therapy in ovarian cancer is mediated via
infiltration of GM!CSF!induced MDSCs
Naoki Horikawa（Shiga Medical Center for Adults）et al.

ISP―31― 6. Overexpression of cyclase!associated protein 2（CAP2）is a new prognostic
indicator in Type II ovarian cancer
Masataka Adachi（Keio University）et al.

ISP―31― 7. The histone methyltransferase, SUV39H2, involved in resistance to anti!
cancertreatment with γ!H2AX production, is a potent therapeutic target in high!
grade
serous ovarian carcinoma
Kenbun Sone
（The University of Tokyo Hospital）et al.

ISP―31― 8. Safety and efficacy of neoadjuvant chemotherapy with bevacizumab in advanced!
stage peritoneal/ovarian cancer patients
Kazunari Fujino（Juntendo University Hospital）et al.

17：40〜18：20 ※ポスター会場①

Group 32 Candidate for Exchange program 2
Chair：Asahikawa Medical University

Yasuhito Kato

ISP―32― 1. Differential requirement of amino acids on cell survival of ovarian cancer cells
Akiko Furusawa（Tokyo Medical and Dental University）et al.

ISP―32― 2. Serum CA125 level after neoadjuvant chemotherapy is predictive of prognosis andsurgical outcomes in advanced epithelial ovarian cancer
Tomohiko Matsuhashi（Nippon Medical School）et al.

― 95 ―日㈮プログラム

Masashi Noguchi（Nagasaki University Hospital）et al.

ISP―30― 9. Fertility Preservation before treatment of malignant disease

11

ISP―32― 3. Investigation for characteristics of clear cell carcinoma between developing and

日㈮
プログラム
11

non!developing endometriosis
Yu Horibe（Tokyo Womenʼs Medical University Hospital）et al.

ISP―32― 4. Clinical impact of routine DNA genotyping on the management of suspected early
hydatidiform mole
Yoko Aoyagi（Oita University Hospital）et al.

ISP―32― 5. Second curettage as initial treatment for molar pregnancy：who can skip it?
Shingo Miyamoto（Showa University）et al.

ISP―32― 6. Limitations of hormonal therapy in adenomyosis patients
Chiho Miyagawa（Kindai University Hospital）et al.

ISP―32― 7. The frequencies of peripheral blood regulatory T cells and activated lymphocytesof the premature ovarian insufficiency
Mutsumi Kobayashi（Toyama University Hospital）et al.

ISP―32― 8. Validity of assisted reproductive technology after laparoscopic myomectomy
Takashi Nakasuji（Tokyo Medical and Dental University）et al.

17：00〜17：40

Group 33 Candidate for Exchange program 3
Chair：Tohoku University Hidekazu Nishigori
ISP―33― 1. Prevention of postpartum depression by the intake of omega!3 polyunsaturated
fatty acids（PUFAs）
Yoko Nagayasu（Osaka Medical College）et al.

ISP―33― 2. Are treatment interventions for early onset gestational diabetes based on theInternational Association of Diabetes and Pregnancy Study Groups criteria
effective?
Yuko Hagiwara（Yokohama City University Medical Center）et al.

ISP―33― 3. Three cases of cesarean scar pregnancy treated with conservative surgery
Haruka Ueda（Niigata University Medical and Dental Hospital）et al.

ISP―33― 4. Non!invasive positive pressure ventilation for preeclamptic women；4 casereports
Kohei Hamada（Kyoto University Hospital）et al.

ISP―33― 5. Study on the Kinetics of Pregnancy!Related Proteins in Primates
Hirofumi Kashiwagi（Tokai University）et al.

ISP―33― 6. Change in fetal cardiac output distribution to the placenta with ritodrine tocolysis
Ryuichi Shimaoka（Gifu University）et al.

17：40〜18：20 ※ポスター会場①

Group 34 Candidate for Exchange program 4
Chair：Nippon Medical School Yoshimitsu Kuwabara
ISP―34― 1. Post!surgical maintenance of cardiac function in an ex vivo premature lamb
model
Yusaku Kumagai（Tohoku University）et al.

― 96 ―

ISP―34― 2. What is useful ultrasound screening for congenital heart disease in the first
Mayumi Tokunaka（Showa University Hospital）et al.

ISP―34― 3. Analysis of fetal gross movements in light for date infants by a fetal movement
acceleration measurement recorder
Masayoshi Morita（Teikyo University Hospital）et al.

ISP―34― 4. Elastography for predicting time to delivery at third trimester
Yoshie Yo（Kindai University Hospital）et al.

ISP―34― 5. Timing of birth for women with a twin pregnancy in the past three years
Aya Yoshida（Kansai Medical University）et al.

ISP―34― 6. Outcomes of placental abruption in 75 patients
Kazuma Onishi（Japanese Red Cross Nagoya Daiichi Hospital）et al.

ISP―34― 7. Hyperfibrinolysis with Consumptive Coagulopathy in Amniotic Fluid Embolism
Tomoaki Oda（Hamamatsu University School of Medicine）et al.

― 97 ―日㈮プログラム

trimester?

11

日㈮
プログラム

第2日

5 月 11 日（金）ポスター会場②
仮設テント：ポスター会場

11

11：10〜11：50

Group 35 Cervical cancer/CIN/SIL 4
Chair：Kumamoto University Hironori Tashiro
ISP―35― 1. Identification of risk factors in patients with positive lymph node after radical
hysterectomy for early stage cervical cancer
Soyi Lim（Gachon University Gil Medical Center, Korea）et al.

ISP―35― 2. Sentinel lymph node mapping using indocyanine green in cervical cancer
Sahori Kakuda（Osaka University）et al.

ISP―35― 3. Extraperitoneal Radical Trachelectomy With Pelvic Lymphadenectomy：A Novel
Fertility!Preserving Option for Early Stage Cervical Cancer Patients
Kazunobu Yagi（Osaka University）et al.

ISP―35― 4. Identifying a candidate population for ovarian conservation in young women withclinical stage IB!
IIB cervical cancer
Imari Deura（St. Marianna University School of Medicine）et al.

ISP―35― 5. Salvage hysterectomy after concurrent chemoradiotherapy for advanced cervicalcancerNatsuko Kamiya（Yokohama City University Hospital）et al.

ISP―35― 6. Efficacy of neoadjuvant chemotherapy plus radical hysterectomy for stage IB2,
IIA2 and IIB cervical cancer
Takahito Ashihara（Shiga Medical Center for Adults）et al.

ISP―35― 7. Comparison of laparoscopic and open radical hysterectomies in the surgicaltreatment of stage IB1 cervical cancer in a single institute in Japan
Tsuyoshi Takiuchi（Osaka University）et al.

ISP―35― 8. A retrospective study of uterine arterial neoadjuvant chemotherapy plus radical
hysterectomy versus radical hysterectomy alone in patients with stage IB2 to IIB
uterine cervical cancer
Takashi Suzuki（Seirei Hamamatsu General Hospital）et al.

ISP―35― 9. Radical hysterectomy after radiotherapy for recurrent or persistent cervicalcancerSeiji Mabuchi（Osaka University）et al.

17：40〜18：20

Group 36 Cervical cancer/CIN/SIL 5
Chair：Jichi Medical University

Hiroyuki Fujiwara

ISP―36― 1. The efficacy of national HPV vaccination program against cervical cancer inJapanese young women
Risa Kudo（Niigata University）et al.

― 98 ―

ISP―36― 2. Correlation among HPV!
derived transcriptomes, HPV types and CIN grades

laser（L!PDT）for Cervical Intraepithelial Neoplasia
Masaru Sakamoto（Sasaki Foundation Kyoundo Hospital）et al.

ISP―36― 4. Posttreatment human papillomavirus testing for residual or recurrent high!
grade
cervical intraepithelial neoplasia：a pooled analysis
Mamiko Onuki（Showa University）et al.

ISP―36― 5. Conservative management for cervical intraepithelial neoplasia during pregnancy
Misato Ogino（Kobe University）et al.

ISP―36― 6. Decision!making with fathers should influence the acceptance of HPV vaccine for
their daughters
Mariko Shindo（Osaka University）et al.

ISP―36― 7. Human papilloma virus（HPV）vaccination in Japan：An estrangement between
self!reported information and municipal personal record of HPV vaccination in
Japanese young women
Manako Yamaguchi（Niigata University）et al.

ISP―36― 8. Management of cervical high!grade squamous intraepithelial lesions（HSIL）
during pregnancy
Yusuke Matsuura（Nursing of Human Broad Development, University ofOccupational and Environmental Health）et al.

ISP―36― 9. Physiciansʼ skill may be a prognostic factor of cervical intraepithelial neoplasia
after CO2 laser vaporization
Koichiro Kawano（Kurume University）et al.

ISP―36― 10. Interim results of a cohort study assessing efficacy of cervical cytology and HPV
testing as modalities for population!based cervical cancer screening
Tohru Morisada（Keio University）et al.

11：10〜11：50

Group 37 Cervical cancer/CIN/SIL 6
Chair：Kindai University Sakai Hospital Kaichiro Yamamoto
ISP―37― 1. Introduction of HPV test for cervical cancer screening in Cambodia as low
resource setting
Maryan Chhit（Khmer!
Soviet Friendship Hospital, Cambodia）et al.

ISP―37― 2. Comparative Study of the effect of cervical cancer screening by Liquid!
Based
Cytology and High!Risk Human Papillomavirus detection in Inner Mongolia
Xianzhi Duan
（Tongren Hospital of Beijing, China）et al.

ISP―37― 3. Cervical Cancer in Women with Squamous Cell Carcinoma Cytology
Chumnan Kietpeerakool（Khon Kaen University, Thailand）et al.

ISP―37― 4. A study of the effectiveness and safety of Bevacizumab combination therapy foradvanced or recurrent cervical cancer
Satomi Kameda（Tohoku University Hospital）et al.

― 99 ―

日㈮プログラム

Satoshi Baba（The University of Tokyo）et al.

ISP―36― 3. Phase I/IIa study of photodynamic therapy using talaporfin sodium and diode11

ISP―37― 5. Examination of adverse gastrointestinal tract events in cases using Bevacizumab

日㈮
プログラム
11

for cervical cancer in our department
Satoshi Nishiyama（Saga University）et al.

ISP―37― 6. Clinical outcomes of bevacizumab in five recurrent patients with uterine cervicalcancer after concurrent chemoradio therapy
Takashi Ushiwaka（Kochi Medical School）et al.

ISP―37― 7. Radiation therapy for para!
aortic lymph node metastasis diagnosed by various
imaging modalities and prognosis for advanced uterine cervical cancer
Kaho Suzuki（Kobe University）et al.

ISP―37― 8. Treatment outcome of the definitive high!dose!
rate brachytherapy combinedwith external beam pelvic radiotherapy for patients with uterine cervical cancer
Hiroshi Matsushima（Kyoto Prefectural University of Medicine）et al.

ISP―37― 9. Two cases of uterine cervical adenocarcinoma with successful systemic
chemotherapy
Hiroshi Kaneda（Juntendo University Shizuoka Hospital）et al.

ISP―37― 10. Limitation of postoperative adjuvant chemotherapy（paclitaxel and carboplatin）
for
treatment of cervical cancer stage I/II patients at high risk of recurrence
Yuki Okuma（Nihon University）et al.

17：40〜18：20

Group 38 Endometrial cancer 3
Chair：Kansai Medical University Masato Kita
ISP―38― 1. A case of acute abdominal pain caused by the infarcted parasitic leiomyoma
Yoojung Lee（Gachon University of Medicine and Science, Korea）et al.

ISP―38― 2. The value of serum LDH, CRP and D!dimer levels for differentiation among
degenerated leiomyoma, variant type leiomyoma and leiomyosarcoma
Kaori Kiuchi（Dokkyo Medical University）et al.

ISP―38― 3. Preoperative prediction of uterine sarcoma using tumor to subcutaneous fat signal
intensity ratio by T2 weighted imaging（TFSIR）
and apparent diffusion coefficient（ADC）on magnetic resonance imaging（MRI）
Yasuko Oka（Komatsu Municipal Hospital）et al.

ISP―38― 4. Coincidental detection of diffuse large B!cell lymphoma in the inner inguinal
lymph node of a woman undergoing pelvic lymph node dissection for uterine
endometrial cancer
Kazuaki Ohashi（Nagasaki University Hospital）et al.

ISP―38― 5. A case of leiomyosarcoma arising from subserosal leiomyoma
Maiko Yamaguchi（Juntendo University Hospital）et al.

ISP―38― 6. A rare case of a primary uterine perivascular epithelioid cell tumor（PEComa）
treated with robotic hysterectomy and adjuvant chemotherapy
Mizuki Isayama（University of Tsukuba）et al.

― 100 ―

ISP―38― 7. Multimodality therapy for the patients with advanced or recurrent uterine
Mizuho Kuroshima（Kobe University）et al.

ISP―38― 8. Use experience of eribulin for recurrent uterine carcinosarcoma
Masato Nishimura（Tokushima University）et al.

ISP―38― 9. Uterine sarcoma：20!
year Our hospital Experience of 21 Cases
Takanori Shimizu（Hachinohe City Hospital）et al.

11：10〜11：50

Group 39 Endometrial cancer 4
Chair：International University of Health and Welfare Mita Hospital Nobuyuki Susumu
ISP―39― 1. Development of a rapid preoperative diagnosis method to assess lymph nodemetastasis in uterine cancer
Emiko Yoshida（Juntendo University）et al.

ISP―39― 2. The real frequency of localized para!aortic lymph node metastasis in endometrial
cancerAsami Toki（Tohoku University Hospital）et al.

ISP―39― 3. Is tumor size really an independent predictor of lymph node metastasis inendometrioid endometrial cancer?
Kento Ohnishi（Center Hospital of the National Center for Global Health andMedicine）et al.

ISP―39― 4. Administration of cabergoline contributes to preserving fertility in young
hyperprolactinemic patients with endometrial cancer treated withmedroxyprogesterone acetate
Munekage Yamaguchi（Kumamoto University）et al.

ISP―39― 5. A retrospective study of endometrial cancer in elderly women aged 80 or older
Souta Tanaka（Hachinohe City Hospital）et al.

ISP―39― 6. Prognostic comparison between laparotomy and laparoscopic surgery for early!
stage endometrial cancer
Mayu Shiomi（Osaka University）et al.

ISP―39― 7. Para!aortic lymphadenectomy at primary surgery is critical for treatment ofendometrial cancer
Osamu Kobayashi（Nihon University Itabashi Hospital）et al.

ISP―39― 8. A risk factor of treatment failure of conservative management of atypicalendometrial hyperplasia and endometrial carcinoma
Masafumi Yasunaga（Kyushu University Hospital）et al.

ISP―39― 9. Diagnostic effectiveness of Sentinel Lymph Node Mapping：Comparison with
MRI, PET/CT in early cervical and endometrial cancer
Jeong-Yeol Park
（University of Ulsan College of Medicine, Asan Medical Center,
Korea）et al.

― 101 ―

日㈮プログラム

leiomyosarcoma

1117：40〜18：20

日㈮
プログラム
11

Group 40 Ovarian/Tubal/Peritoneal cancer 4
Chair：Kawasaki Medical School Mitsuru Shiota
ISP―40― 1. Efficacy and Safety of En bloc Total Parietal Peritonectomy for Primary or
Recurrent Ovarian Cancer with Peritoneal Carcinomatosis
Aeran Seol
（Seoul National University College of Medicine, Korea）et al.

ISP―40― 2. Reporting of Double Cancer Survivor：10 years survival from Synchronous
Ovarian and Colorectal Tumour Post!Surgery Post Chemotherapy
Eugene Leong Weng Kong
（Taylors University School of Medicine,
Malaysia）et al.

ISP―40― 3. Preoperative neutrophil/lymphocyte ratio and CA125 may be predictive factors
for recurrence in stage I ovarian clear cell carcinoma
Yuji Takei（Jichi Medical University）et al.

ISP―40― 4. Risk Factors for Venous Thromboembolism in Women with Ovarian Cancer
Tetsuya Kawaguchi（Kobe University）et al.

ISP―40― 5. Incidence and timing of venous thromboembolism in patients with ovarian cancer
undergoing primary treatment
Mizuki Uenaka（Kobe University）et al.

ISP―40― 6. Clinical characteristics of patients with ovarian cancer developing VTE
Kohei Yamaguchi（The University of Tokyo Hospital）et al.

ISP―40― 7. Efficacy and safety of bevacizumab for advance and recurrent Mülleriancarcinoma
Hiroaki Matsubara（Osaka City University）et al.

ISP―40― 8. Retrospective analysis of stage II〜IV epithelial ovarian cancer patients treatedwith systematic pelvic and para!
aortic lymphadenectomy followed bychemotherapy
Koutarou Sueoka（Yamaguchi University）et al.

ISP―40― 9. Drug!induced aortitis in a patient with ovarian cancer treated with bevacizumab
combination therapy
Soshi Kusunoki（Juntendo University）et al.

ISP―40― 10. Identification of Potential Biomarkers of recurrent advanced ovarian cancer
during bevacizumab maintenance therapy as part of first!
line treatment
Ryosuke Saito（The Jikei University School of Medicine）et al.

11：10〜11：50

Group 41 Ovarian/Tubal/Peritoneal cancer 5
Chair：Tokyo Medical University Fumitoshi Terauchi
ISP―41― 1. Prognostic value of preoperative lymphocyte!
monocyte ratio in elderly patientswith advanced epithelial ovarian cancer
Hyun Joo Lee（Pusan National University Hospital, Korea）et al.

― 102 ―

ISP―41― 2. Differences in correlation of Progression!Free Survival and Overall Survival byHyea Park（Samsung Medical Center, Sungkyunkwan University School of
Medicine, Korea）et al.

ISP―41― 3. Pathological findings and prognosis of ovarian epithelial!borderline malignant
tumorsYoshiko Oyama（Tohoku University）et al.

ISP―41― 4. Primary Fallopian Tube Cancer：Clinicopathological Features of Tumor
occupying Lesions
Shoko Sakurada（Tohoku University）et al.

ISP―41― 5. Treatment!free interval（TFI）is useful not only for choice of second!line agents
but for prognostic factor in ovarian high!grade serous carcinoma cases stage III/IV
Remi Hasegawa（Nihon University）et al.

ISP―41― 6. Oligoclonality following chemotherapy in high grade serous ovarian cancer
Hisamitsu Takaya（Kindai University）et al.

ISP―41― 7. Difference in prognosis and prognostic factors of patients with epithelial ovariancancer according to age
Masahiro Shimomura（Osaka City University）et al.

ISP―41― 8. Hyperfibrinogenemia shortens progression!free survival in women with ovariancancerYuka Murata（Kobe University）et al.

ISP―41― 9. Diagnostic utility of peritoneal effusion cell!block and immunocytochemistry foradvanced!stage ovarian/peritoneal cancer prior to neoadjuvant chemotherapy
Yasuhiko Ebina（Kobe University）et al.

17：40〜18：20

Group 42 Ovarian/Tubal/Peritoneal cancer 6
Chair：Kindai University Nara Hospital

Hidekazu Oi

ISP―42― 1. Effect of red ginseng on genotoxicity and health!
related quality of life after
adjuvant chemotherapy in patients with epithelial ovarian cancer：a randomized,
double blind, placebo!controlled trial
Soo Jin Park
（Seoul National University College of Medicine, Korea）et al.

ISP―42― 2. Practice patterns of debulking surgery for advanced!stage ovarian cancer：
analysis from national and society!
sponsored surveys
Soyeon Kweon（Seoul National University College of Medicine, Korea）et al.

ISP―42― 3. The clinical significance of tertiary lymphoid structures（TLS）and tumor
infiltrating B cells in ovarian cancer
Masayo Ukita（Kyoto University）et al.

ISP―42― 4. Management of a ruptured perivascular epithelioid cell tumor during and after
pregnancy：a case report
Kenta Nitahara（Japanese Red Cross Ishinomaki Hospital）et al.

― 103 ―日㈮プログラム

clinical variables in epithelial ovarian cancer

11

ISP―42― 5. A case of a postmenopausal woman with a spontaneously ruptured seromucinous

日㈮
プログラム
11

borderline tumor of the ovary：A review of the literature
Mamiko Ohta
（Chibune General Hospital）et al.

ISP―42― 6. Advanced ovarian cancer developing in a cyst of the canal of Nuck
Kazue Togashi（Japanese Red Cross Akita Hospital）et al.

ISP―42― 7. A case of neuroendocrine carcinoma developing from the broad ligament of theuterusYui Itonaga（Oita University Hospital）et al.

11：10〜11：50

Group 43 Ovarian/Tubal/Peritoneal cancer 7
Chair：Keio University

Eiichiro Tominaga

ISP―43― 1. Incidence and clinical outcomes of ovarian clear cell carcinoma in surgicallyresected endometrioma
Jinju Lee
（Seoul St. Maryʼs Hospital, The Catholic University of Korea,
Korea）et al.

ISP―43― 2. Primary retroperitoneal Müllerian adenocarcinoma（PRMA）：A Case Report andReview of the Literatures
Chia-Yi Lee（National Taiwan University Hospital, Taiwan）et al.

ISP―43― 3. Alpha!
fetoprotein!producing ovarian malignant tumor in a postmenopausal
woman
Shozo Yoshida（Osaka Gyoumeikan Hospital）et al.

ISP―43― 4. A case of Serous Tubal Intraepithelial Carcinoma detected by abnormal cervicalcytology
Masahiro Sumitomo（Shiga Medical Center for Adults）et al.

ISP―43― 5. Malignant ovarian tumors diagnosed after laparoscopic surgery at a generalgynecological unit
Yoko Hasumi（Mitsui Memorial Hospital）et al.

ISP―43― 6. Endometrioid adenocarcinoma arising from deep infiltrating endometriosis
involving the bladder：A case report and review of the literature
Yosuke Tarumi（Kyoto Prefectural University of Medicine）et al.

17：40〜18：20

Group 44 Other malignant or benign tumor 2
Chair：Oita University Kaei Nasu
ISP―44― 1. Video endoscopic inguinal lymphadenectomy via the hypogastric subcutaneous
approach（VEIL!H）：A preliminary series report
Yifeng Wang
（Southern Medical University, China）et al.

ISP―44― 2. Repurposing itraconazole as an anticancer agent：rapid clinical response ofmetastatic vaginal melanoma
Roze Nakata（The Hospital of Hyogo College of Medicine）et al.

― 104 ―

ISP―44― 3. Anaplastic lymphoma kinase!
negative uterine inflammatory myofibroblastic
Akimasa Takahashi（Nagahama City Hospital）et al.

ISP―44― 4. Trousseauʼs syndrome associated with gynecologic malignancies.

11

Clinicopathologic features of 11 cases
Kazuya Onuma（Shonan Kamakura General Hospital）et al.

ISP―44― 5. Vulvar apocrine adenocarcinoma responded to weekly paclitaxel and biweekly
bevacizumab. A case report
Shinichiro Saeki（The Hospital of Hyogo College of Medicine）et al.

ISP―44― 6. Three different clinical courses and the conservative management of uterine
arteriovenous malformation（AVM）diagnosed by color Doppler ultrasonography
Madoka Tsuzuki（Itabashi Chuo Medical Center）et al.

ISP―44― 7. A case of lymphangiomyomatosis with suspected primary peritoneal cancer andstruggling to control ascites
Ken Matsukuma（Kurume University Hospital）et al.

ISP―44― 8. A case of amelanotic malignant melanoma arising from vagina
Takashi Hirayama（Juntendo University Hospital）et al.

ISP―44― 9. Isolated fallopian tube torsion diagnosed and treated with laparoscopic surgery
Yuji Takahashi（Kyoto Prefectural University of Medicine）et al.

ISP―44― 10. Primary peritoneal malignant mesothelioma with massive ascites：a case report
Yayoi Higuchi（Kochi Medical School）et al.

11：10〜11：50

Group 45 Perinatal care 2
Chair：Dokkyo Medical University Susumu Miyashita
ISP―45― 1. Epidemiology of prolonged pregnancy in Mongolia：Incidence and risk factors
Saruulsaikhan Erdenebat（Mongolian National University of Medical Sciences,
Mongolia）et al.

ISP―45― 2. JICA projects to disseminate cardiotocography in Mongolia
Kazutomo Ohashi（Osaka University, Division of Health Sciences）et al.

ISP―45― 3. An effective introduction and practice of DRCBRAVADO as an educational toolof Cardiotocogram for medical students in bed!side learning
Mariko Watanabe（Dokkyo Medical University）et al.

ISP―45― 4. Imprisoned and Pregnant：Evaluating the Use of Correctional Restraints
Mallory Fox（University of Florida College of Medicine, USA）et al.

ISP―45― 5. Determinants of Utilization of Antenatal Care Services among Women in
Kungyangone Township, Myanmar
San San Myint（University of Medicine 1, Myanmar）

ISP―45― 6. Transvaginal And Colour Doppler Ultrasound In Pregnant Women With Previous
Caesarean Scar With Placental Praevia
Mar Ma Wynn
（University of Medicine 1, Myanmar）― 105 ―

日㈮プログラム

tumor containing the ETV6!NTRK3 fusion gene：the first case reportISP―45― 7. Fear of childbirth and associated factors among pregnant women in Siriraj

日㈮
プログラム
11

Hospital
Matus Phunyammalee（Siriraj Hospital, Thailand）et al.

ISP―45― 8. Evidence of exposure to chemicals and heavy metals during pregnancy inJapanese women
Ryo Maekawa（Yamaguchi University）et al.

ISP―45― 9. Impact of maternal inadequate gestational weight gain on neonatal birth weight inJapanese women
Satoru Ikenoue（Keio University）et al.

ISP―45― 10. Fluctuation of Oral Microbiome during pregnancy in Maternity Log Study
Riu Yamashita（Tohoku University Tohoku Medical Megabank
Organization）et al.

17：40〜18：20

Group 46 FGR
Chair：Nippon Medical School Tama Nagayama Hospital Akihito Nakai
ISP―46― 1. Expression of progesterone induced blocking factor（PIBF）in women with severe
fetal growth restriction
Tomohiro Oba（Showa University）et al.

ISP―46― 2. Systolic and diastolic time interval ratios of the ductus venosus flow velocity
waveform in fetal growth restriction
Natsuko Yokoi（Osaka City University）et al.

ISP―46― 3. Biomarkers for predicting delivery before 34 weeks of gestation in fetal growth
restriction
Akihiro Kawashima（Showa University）et al.

ISP―46― 4. Superb microvascular imaging of the fetus, placenta, and umbilical cord
Kenta Yamamoto（Kagawa University）et al.

ISP―46― 5. Fetal echocardiographic evaluation of dilated cardiomyopathy during mousepregnancy
Takao Owa
（National Cerebral and Cardiovascular Center, Department ofRegenerative Medicine）et al.

ISP―46― 6. Relationship between maturation of the autonomic nervous system in fetal growth
restricted mice and onset of cerebral hemorrhage at ischemia!reperfusion load
Takahiro Minato（Tohoku University Hospital）et al.

ISP―46― 7. Low socioeconomic status is a risk factor for small for gestational age birth inJapan
Ken Yamaguchi（Kyoto Medical Center）et al.

ISP―46― 8. Clinical significance of umbilical venous NT!
proBNP and troponin T in the caseswith at!
risk for fetal circulatory compromise before 36 weeksʼ gestation
Takaaki Shinagawa（Kurume University Hospital）et al.

― 106 ―

11：10〜11：50

Chair：Jichi Medical University Saitama Medical Center Kenjiro Takagi
ISP―47― 1. 17!alpha!hydroxyprogesterone caproate combined maintenance tocolysis could
prolong gestational period in case of preterm labor with mild intra!
amniotic
inflammation
Satoshi Yoneda（University of Toyama）et al.

ISP―47― 2. Neurological outcome in preterm infants with maternal Tocolytic management
Emi Kino（University of Miyazaki Hospital）et al.

ISP―47― 3. Changes of leukocyte migration during pregnancy
Ai Takamizu（Juntendo University）et al.

ISP―47― 4. Longitudinal Lifestyle Monitoring for Prediction of Preterm Birth in Maternity
Log Study
Daisuke Ochi（NTT DOCOMO, INC./Tohoku University Tohoku Medical
Megabank Organization）et al.

ISP―47― 5. The effect of antepartum MgSO4 therapy on pathological chorioamnionitis andinfants outcome
Masanao Ohashi（Miyazaki Medical Association Hospital）et al.

ISP―47― 6. Accuracy of maternal clinical signs for prediction of histological chorioamnionitis
in preterm labor
Yohei Maki
（University of Miyazaki）et al.

17：40〜18：20

Group 48 Fetal complication 2
Chair：Shinshu University Makoto Kanai
ISP―48― 1. Case report of spontaneous septostomy of the dividing membrane accompaniedwith cord entanglement in a monochorionic diamniotic twin：Importance ofidentification of dividing membrane
Tomoki Kotera（Takatsuki General Hospital）et al.

ISP―48― 2. The outcome of fetoscopic laser photocoagulation using the Solomon techniqueversus selective coagulation for twin!twin transfusion syndrome
Seiji Kanazawa（National Center for Child Health and Development）et al.

ISP―48― 3. Meckel!
Gruber syndrome involving both fetuses in a DD twin pregnancy, a casereportShoko Ochiai（Dokkyo Medical University Hospital）et al.

ISP―48― 4. What should we know about Turner syndrome before pregnant?
!2 cases with different outcomes!
Tomohiro Arai（Center for Maternal, Fetal and Neonatal Medicine, Saitama
Medical Center, Saitama Medical University）et al.

ISP―48― 5. Case Report：The outcomes of fetal bradycardia
Ryoko Ono（Sakakibara Heart Institute）et al.

― 107 ―日㈮プログラム

Group 47 Preterm labor 2

11

ISP―48― 6. Prenatal diagnosis of hypospadias in a tertiary care center：a retrospective

日㈮
プログラム
11

analysis of 10 years
Takashi Kaji
（Tokushima University Hospital）et al.

ISP―48― 7. Novel technique to assess fetal fractional shortening by two!dimensional tracking
Sumito Nagasaki（Toho University Omori Medical Center）et al.

ISP―48― 8. A case with BASM（biliary atresia splenic malformation）syndrome diagnosed
with agenesis of inferior vena cava without visceral heterotaxy in utero
Kunio So
（Kurume University Hospital）et al.

ISP―48― 9. Prenatal genetic diagnosis for neonatal alloimmune thrombocytepenia for womenwith the history of neonatal alloimmune thrombocytopenia
Akari Shirakuni（Kobe University Hospital）et al.

ISP―48― 10. Chromosomal abnormalities：ultrasonographic soft signs in first and second
trimester―an evidence!based review
Coralia Stefanescu（Euromaterna Hospital, Romania）et al.

11：10〜11：50

Group 49 Maternal complication 4
Chair：Saitama Medical University Yoshimasa Kamei
ISP―49― 1. Intracranial pathologies during pregnancy
Yuri Niwa（Nagoya University）et al.

ISP―49― 2. Five cases of intracranial diseases in pregnant women
Chie Koide（Hiroshima University Hospital）et al.

ISP―49― 3. Impact of maternal schizophrenia on protein expression of fetal immune system
Yoshinori Moriyama（Nagoya University）et al.

ISP―49― 4. Maternal myasthenia gravis：Management of labor and delivery
Kotoi Tsurane（Tokyo Metropolitan Tama Medical Center）et al.

ISP―49― 5. Case Report：Nonimmune Fetal Hydrops Following Maternal Suicide Attempt
Kristen Elmezzi（Walter Reed National Military Medical Center, USA）et al.

ISP―49― 6. Postnatal depression associated with pregnancy induced by assisted reproductive
technology
Haruhiko Udagawa（The Jikei University School of Medicine）et al.

ISP―49― 7. Clinical study of pregnant women with psychotic disorders
Sara Takahashi（Hachinohe City Hospital）et al.

ISP―49― 8. The Effect of the Edinburgh Postnatal Depression Scale at Postpartum Checkup
Asuka Tachi（Nagoya University）et al.

17：40〜18：20

Group 50 Maternal complication 5
Chair：Fujita Health University Takao Sekiya
ISP―50― 1. Obstetric and neonatal complications in pregnancies achieved by oocyte donationin our institution
Naoko Takahashi（Osaka University）et al.

― 108 ―

ISP―50― 2. Analysis on the perinatal outcome of pregnant patients complicated withKunihiko Yoshida（Niigata University Medical and Dental Hospital）et al.

ISP―50― 3. Live birth after intravenous treatment for uterine arteriovenous malformation, acase report
Kazumi Tada
（Dokkyo Medical University）et al.

ISP―50― 4. Mild paroxysmal nocturnal hemoglobinuria in pregnancy, that was difficult todistinguish from hemolysis, elevated liver enzymes, and low platelet countsyndrome：A case report
Youhei Tsunoda（Nippon Medical School）et al.

ISP―50― 5. Uterine prolapse during pregnancy：two case reports
Yuta Momono（Tohoku University Hospital）et al.

ISP―50― 6. Shakuyakukanzoto could be an effective treatment for a pregnant women withlumbar disk herniation and crampy pain
Miyuki Terata（Iwate Medical University）et al.

11：10〜11：50

Group 51 Abnormal delivery 2
Chair：Kobe University

Masashi Deguchi

ISP―51― 1. Predicting Data!based Induction Interval of Labor Induction with Titrated Oral
Misoprostol Solution
Shi-Yann Cheng（China Medical University of Taiwan, Taiwan）et al.

ISP―51― 2. Comparison of maternal and perinatal morbidity in term breech presentation
between elective and emergency cesarean section
Benjamas Kitnithee（Siriraj Hospital, Mahidol University, Thailand）et al.

ISP―51― 3. Uterine tonic contraction after initiation of oxytocin infusion for induction oraugmentation of labor
Takahiro Yamashita（Aiiku Hospital）et al.

ISP―51― 4. Can we stop Oxytocin after entering the active phase of labor for fetal growth
restriction（FGR）babies；pros. or cons?
Sayuri Iwai
（Osaka University）et al.

ISP―51― 5. Risk factors for nonreassuring fetal status before labor in the presence ofpremature rupture of membranes
Urara Idei
（Yamagata University Hospital）et al.

ISP―51― 6. A Potential Contribution of Bradykinin Receptor B1 Agonist to the Mechanism ofDevelopment of Myometrial Interstitial Edema
Yi Shen（Hamamatsu University School of Medicine）et al.

ISP―51― 7. Pregnancy outcomes subsequent to uterine arterial embolization for severe post!
partum hemorrhage
Hitomi Imafuku（Kobe University Hospital）et al.

ISP―51― 8. Promotion of a new technique for cesarean section at full dilatation
Kotaro Shimura（Osaka University）et al.

― 109 ―

日㈮プログラム

inflammatory bowel disease11

17：40〜18：20

日㈮
プログラム
11

Group 52 Abnormal delivery 3
Chair：Yamaguchi University Ryo Maekawa
ISP―52― 1. Non!Invasive Monitoring of the Cardiac Effects of Continuous Intravenous
Oxytocin Infusion during Cesarean Delivery
Kayo Tanaka（Mie University）et al.

ISP―52― 2. Evaluation of circulatory dynamics during cesarean section using electrical
cardiometry
Atsuko Hichijo（Tokushima University）et al.

ISP―52― 3. Outcome of twin delivery：A single center experience
Masami Hayashi（Osaka City University）et al.

ISP―52― 4. A study of factors associated with increased lactic acid levels in umbilical arterial
blood
Ryuhei Kurashina（Nippon Medical School Hospital）et al.

ISP―52― 5. The Origin of Inflammation in the Pathophysiology of Postpartum Acute
Myometritis involved in Amniotic Fluid Embolism
Divyanu Jain
（Hamamatsu University School of Medicine）et al.

ISP―52― 6. A case of unscarred uterine rupture：A rare and difficult diagnosis
Shihori Nishizawa（Juntendo University Shizuoka Hospital）et al.

ISP―52― 7. What kind of risk factors can foresee the postpartum hemorrhage after vaginal
delivery in uncomplicated pregnancy?
Kazuhiro Nishioka（Yamato Takada Municipal Hospital）et al.

11：10〜11：50

Group 53 Abnormal pregnancy
Chair：Tokyo Womenʼs Medical University Medical Center East

Koichiro Takagi

ISP―53― 1. Clinical outcome of linear salpingotomy for a different lesion of tubal pregnancy
Toshimichi Oki（Kagoshima University School of Health Sciences）et al.

ISP―53― 2. Impact of parity on the transition of fetal presentation transition during pregnancy
Shogo Yamaguchi（The University of Tokyo Hospital）et al.

ISP―53― 3. A case review of methotrexate therapy in ectopic pregnancy
Yoshihide Inayama（Toyooka Hospital）et al.

ISP―53― 4. Two cases of uterine rupture occurred during second trimester
Ryo Uemura（Osaka City University）et al.

ISP―53― 5. Obstetric Outcome of Subsequent Pregnancy following Uterine Artery
Embolization for postpartum hemorrhage
Mariko Jitsumori（Osaka University）et al.

ISP―53― 6. Epidemiology of ectopic pregnancy：incidence, risk factors and outcomes in
Mongolia
Tsevelmaa Baldan（Marie Stopes International Mongolia, Mongolia）et al.

― 110 ―

17：40〜18：20

Chair：University of Miyazaki Masatoki Kaneko
ISP―54― 1. CD59 expression on human extravillous trophoblast may be regulated bysurrounding microenvironment
Masashi Ueda（Kyoto University）et al.

ISP―54― 2. Serum autotaxin level as a biomarker for placental function
Yumiko Nishimori（The University of Tokyo）et al.

ISP―54― 3. Transport mechanism of nicotine in BeWo cells
Takako Sadakane（Hiroshima University）et al.

ISP―54― 4. Accumulation of prostaglandin E2 in amniotic fluid and expression of PGE
synthases and transporters during human labor
Nanase Takahashi（Juntendo University Hospital）et al.

ISP―54― 5. Expression of TrkB isoforms in FGR and non!FGR
Akane Kondo（Shikoku Medical Center for Children and Adults）et al.

ISP―54― 6. Effects of TNF!α and IGF!I on proliferation and angiogenesis of BeWo cells
Kei Tanaka（Kyorin University）et al.

ISP―54― 7. The study for the effect of different diameter in bilateral umbilical arteries on theformation of umbilical twist
Masamitsu Nakamura（Showa University）et al.

11：10〜11：50

Group 55 HDP 2
Chair：Tokyo Womenʼs Medical University Masaki Ogawa
ISP―55― 1. Soluble endoglin!inhibited autophagy enhances LPS!
inducing inflammasome
production in peripheral blood of pregnant women
Akitoshi Nakashima（University of Toyama）et al.

ISP―55― 2. Association between birth weight and subsequent risk for hypertensive disordersof pregnancy
Maiko Wagata（Tohoku University Tohoku Medical Megabank
Organization）et al.

ISP―55― 3. A role of Sonic hedgehog pathway in preeclamptic placenta
Hiroshi Takai（Kyoto University）et al.

ISP―55― 4. Correlation between intracranial imaging by MRI and development at age of 3 inthe children born from mothers with hypertensive disorders of pregnancy orspontaneous preterm birth
Tae Kusabiraki（University of Toyama）et al.

ISP―55― 5. A novel of biomarker profiles in experimental aged maternal mouse withhypertensive disorders of pregnancy
Kiichiro Furuya（Osaka University）et al.

― 111 ―日㈮プログラム

Group 54 Placenta 2

11

ISP―55― 6. Risk Factors for Bleeding Complications after Cesarean Section among

日㈮
プログラム
11

Preeclampsia Cases Followed by Postoperative Prophylactic Anticoagulation
Naoya Tsujimoto（Tokyo Metropolitan Bokutoh Hospital）et al.

17：40〜18：20

Group 56 Puberty/Menstrual disorder
Chair：Iwate Medical University Jin Kumagai
ISP―56― 1. Examination of the influence of infectious stress in postnatal period on sexual
behavior of male rats in adulthood
Mayila Yiliyasi（Tokushima University）et al.

ISP―56― 2. The influence of early life psychological stress on sexual maturation and on sexual
activity in female rats
Kiyohito Yano
（Tokushima University）et al.

ISP―56― 3. Nine cases of Turner syndrome with differences in menstrual abnormality andphysical findings
Makiho Ishibashi（Fukushima Medical University）et al.

ISP―56― 4. Five patients with vaginal agenesis treated using non surgical vaginoplasty using
uterine cervical dilators
Akiko Kawasaki（University of Tsukuba）et al.

ISP―56― 5. The retrospective analysis of 53 patients of primary amenorrhea
Yuri Miyahara（Okayama University）et al.

11：10〜11：50

Group 57 ART 2
Chair：Nagoya University Akira Iwase
ISP―57― 1. The role of endometrial and uterine vascular status measurement in predicting
pregnancy outcome in frozen thawed embryo transfer cycles
Byung Kyoo Park
（Pusan National University Hospital, Korea）et al.

ISP―57― 2. Endometrial Receptivity Array：Retrospective Review of Reproductive
Outcomes Among Patients with Personalized Embryo Transfer（pET）
Justin Tan（University of British Columbia, Canada）et al.

ISP―57― 3. Retrospective study on the clinical efficacy of single embryo transfer（SET）for
IVF!adverse cases；a single IVF center
Kaori Shinya（Nihon University）et al.

ISP―57― 4. Cases that needed GnRH agonist in artificial FET cycle
Yuri Yamamoto（Tokushima University）et al.

ISP―57― 5. Impact of ovarian stimulation protocols on perinatal outcomes in fresh single!
embryo transfers：Analysis of 36,469 singleton deliveries in Japanese Assisted
Reproductive Technology Registry between 2007 and 2013
Seungchik Jwa（Saitama Medical University）et al.

― 112 ―

ISP―57― 6. A long!term cohort study on 3,509 babies born through assisted reproductive
Kensuke Akitsu（Tokyo Medical University Hospital）et al.

ISP―57― 7. Hysteroscopy performed at mid!luteal period of previous cycle of ART treatment
did not improve the uterine receptivity for embryo but might cause the overinvasive examination
Kyoko Nishimura（Yamagata University）et al.

ISP―57― 8. Treatment outcome of In Vitro Fertilization―Embryo transfer in patients who
have treated abnormal thyroid function
Chiaki Heshiki（University of the Ryukyus）et al.

17：40〜18：20

Group 58 ART 3
Chair：Tokai University Shunichiro Izumi
ISP―58― 1. The comparison between mechanical and laser assisted hatching in Frozen!
thawed blastocyst transfer cycles：A retrospective study of clinical outcomes
Moosung Jo（Pusan National University Hospital of Korea, Korea）et al.

ISP―58― 2. The efficacy of in vitro Fertilization（IVF）in treating vaginismus causing
infertility：a retrospective analysis of 13 cases
Ying-Wen Wang
（Kaohsiung Chang Gung Memorial Hospital, Taiwan）et al.

ISP―58― 3. Shall we Pause PGS?
Shizuko Takahashi（The University of Tokyo）et al.

ISP―58― 4. A comparative retrospective study between controlled hyper!stimulation andmild!stimulation protocol for women with low AMH value
Rena Toriumi（Kyorin University Hospital）et al.

ISP―58― 5. The interval between oocyte retrievals was not correlated with the number of
eggs retrieved
Takeshi Fukunaga（Yamagata University）et al.

ISP―58― 6. Successful delivery in a 44!
year!old woman using vitrified human oocytes takenfrom the woman at 41 years of age
Miyako Funabiki（Oak Clinic）et al.

ISP―58― 7. Effect of resveratrol supplementation during embryo transfer on IVF outcomes ininfertile women：a cross!sectional study
Asako Ochiai（Juntendo University Hospital）et al.

ISP―58― 8. A Study on the usefulness of hysteroscopy for ET repeated failure cases in ART
Yusuke Fukuda（Toho University Omori Medical Center）et al.

― 113 ―日㈮プログラム

technology（ART）for 6 years of age

11

11：10〜11：50

日㈮
プログラム
11

Group 59 Reproductive physiology/Endocrinology 2
Chair：Yamagata University Jun Kawagoe
ISP―59― 1. The regulation of endoplasmic reticulum stress improved the development of aged
oocytes
Isao Takehara（Yamagata University）et al.

ISP―59― 2. Novel antigens involved in ovarian autoimmunity in POI（primary ovarian
insufficiency）, and their localization and function in the human ovary
Satoko Osuka（Nagoya University）et al.

ISP―59― 3. The effects of chronic testosterone administration on body weight, food intake, andfat weight were changed age!dependently
Takeshi Iwasa（Tokushima University）et al.

ISP―59― 4. Impact of vitamin D supplementation on preconception immune tolerance ininfertile women
Yuko Ikemoto（Juntendo University Hospital）et al.

ISP―59― 5. Effect of metformin on androgen receptor expression in endometrial epithelial/
stromal cell lines
Miki Ohara（Fukushima Medical University）et al.

ISP―59― 6. The Effectiveness of a New Comprehensive Numerical Multi!
Scoring System forEndometriosis
Masao Ichikawa（Nippon Medical School Hospital）et al.

ISP―59― 7. Efficacy of individualized dose of FSH in ovarian stimulation for unexplained
sterility
Toshiya Matsuzaki（Tokushima University）et al.

ISP―59― 8. Comparison of Anti!
Müllerian!
Hormone levels between pregnant women withnatural conception and sterile women in assisted reproductive technology
Kento Usui（Toho University Omori Medical Center）et al.

ISP―59― 9. Individualized initial dose in low!
dose FSH therapy for WHO group 2 patients
Rie Yanagihara（Tokushima University）et al.

17：40〜18：20

Group 60 Endometriosis 2
Chair：Toho University Omori Medical Center Mineto Morita
ISP―60― 1. Dominant expression of angiotensin 1!7 receptor（MAS1）in the eutopic
endometrium in the endometriosis patients
Takahiro Nakajima（Nihon University Itabashi Hospital）et al.

ISP―60― 2. Clonal expansion and diversification of cancer!
associated mutations in
endometriosis and normal endometrium
Kazuaki Suda（Niigata University）et al.

― 114 ―

ISP―60― 3. Treatment with a selective estrogen receptor modulator, SR!
16234 results in
Khine Yinmon（Tottori University）et al.

ISP―60― 4. Role of Focal Adhesion Kinase（FAK）in development of endometriosis
Takashi Nagai（Nagoya University）et al.

ISP―60― 5. Peritoneal NK cell suppression for cytotoxicity and chemotaxis in women withendometriosis
Shimpei Yamamoto（Kochi University）et al.

11：10〜11：50

Group 61 Womenʼs health care
Chair：Kansai Medical University Katsuhiko Yasuda
ISP―61― 1. Healthcare for young gynecologic malignant tumor patients at our hospital
Kanako Yoshida（Tokushima University）et al.

ISP―61― 2. Intraoperative Surgical Apgar Score predicts 30!day morbidity in elderly
gynecological patients
Kazumi Kurata（University of Fukui）et al.

ISP―61― 3. The comparison of lower urinary tract symptoms after various surgeries for pelvic
organ prolapse
Kaori Hoshino（Wakamatsu Hospital of the University of Occupational andEnvironmental Health）et al.

ISP―61― 4. The restoration of vaginal front and posterior wall together is necessary withNative Tissue Repair in the case of grade III and IV of Pelvic Organ Prolapse
Tetsuya Oishi（Takatsuki General Hospital）et al.

ISP―61― 5. Four cases of Pelvic Organ Prolapse（POP）complicated with uterine cancer or
precancerous lesion
Ayuko Otoshi（Osaka Police Hospital）et al.

ISP―61― 6. Repair of the Stage 3 POP That a Ring Pessary Made Giant Rectovaginal Fistulas
and the Rectal Mucosa Covered the Posterior Vaginal Wall Beyond the Fistula：
Operative Technique
Hiroki Kato（Takatsuki General Hospital）et al.

ISP―61― 7. Effects of drospirenone on adhesion molecule expression and monocyte adherencein human endothelial cells
Fumitake Ito（Kyoto Prefectural University of Medicine）et al.

ISP―61― 8. Levonorgestrel intrauterine system for previous delivery scar defect related
postmenstrual bleeding management
Ying-Yi Chen
（Kaohsiung Chang Gung Memorial Hospital and Chang Gung
University College of Medicine, Taiwan）et al.

― 115 ―

日㈮プログラム

regression of endometriosis!like lesions in a murine model11

17：40〜18：20

日㈮
プログラム
11

Group 62 Endometriosis 3/Adenomyosis
Chair：Tokyo Medical and Dental University Masakazu Terauchi
ISP―62― 1. Clinical features of Thoracic endometriosis：a series of 25 cases from a single
facility
Shinya Fukuda（The University of Tokyo Hospital）et al.

ISP―62― 2. Alteration of coagulation status in the patients with endometriotic cysts
Kanoko Shoji（Nihon University Itabashi Hospital）et al.

ISP―62― 3. Laparoscopic cystectomy of endometrioma（LC）followed by oral contraceptives（OC）until conception is desired；will this sustain later fecundability?
Arisa Takeuchi（The University of Tokyo）et al.

ISP―62― 4. Dienogest therapy at the early stages of recurrence of endometrioma following
primary surgery suppresses the aggravation of the disease
Akemi Koshiba（Kyoto Prefectural University of Medicine）et al.

ISP―62― 5. Validity of management against the endometriotic cyst：a retrospective study
Takeharu Kido（Kansai Medical University）et al.

ISP―62― 6. Long!term dienogest administration in patient with symptomatic adenomyosis
Kazuaki Neriishi（The University of Tokyo Hospital）et al.

ISP―62― 7. Unusual hyper!inflammatory degeneration of adenomyosis after cesarean section
Atsushi Fusegi（Tokyo Metropolitan Tama Medical Center）et al.

ISP―62― 8. Analysis of clinical problems in medical treatment for adenomyosis
Minako Koizumi（Mitsui Memorial Hospital）et al.

ISP―62― 9. Cystic adenomyoma uteri confused with LEGH in Diagnosis
Yoko Tsuzuki（Teine Keijinkai Hospital）et al.

11：10〜11：50

Group 63 Surgery 2
Chair：Fukushima Medical University Hiromi Komiya
ISP―63― 1. The size of endometrial polyps as predictors of spontaneous vanishing prior tosurgical procedures：a retrospective analysis of hysteroscopic endometrial
polypectomy
Eriko Yano
（Teikyo University Hospital, Mizonokuchi）et al.

ISP―63― 2. Analysis of the effect of microwave endometrial ablation for dysmenorrhea
Yoshinobu Hamada（Dokkyo Medical University Saitama Medical Center）et al.

ISP―63― 3. Two cases of combined medical and surgical management of rudimentary uterine
horn pregnancy
Daisuke Suzuki（Fukushima Medical Center for Children and Women）et al.

ISP―63― 4. Less invasive and easier vaginoplasty using laparoscopy and atelocollagen sponge
Yoshiya Miyahara（Kobe University）et al.

ISP―63― 5. The efficacy of laparoscopic omentectomy in patients with gynecological cancer
Risa Yoshimoto（TOYOTA Memorial Hospital）et al.

― 116 ―

ISP―63― 6. Two cases of surgically treated genital chronic graft!
versus!host disease in
Yasuhiko Kamada（Okayama University Hospital）et al.

ISP―63― 7. A retrospective review of re!laparoscopy cases due to postoperative bleeding
after laparoscopic surgery：Sequential monitoring of intra!abdominal drainage
volume and vital sign trend for prompt diagnosis and intervention
Keisuke Murakami（Juntendo University Hospital）et al.

ISP―63― 8. Two cases of perineal plastic operation for patients of persistent cloaca
Mayu Nagata（Kyushu University）et al.

ISP―63― 9. Tumorectomy for gynecological cancer recurrence：case series
Sen Wakahashi（Kobe University Hospital）et al.

ISP―63― 10. Women with Acute Abdomen and its Laparoscopic Management―Senerio in
Developing country
Jyoti Chaube（St. Judeʼs Hospital, India）et al.

17：40〜18：20

Group 64 Uterine leiomyoma 2
Chair：Saitama Medical University Ryugo Okagaki
ISP―64― 1. Subserosal Leiomyoma Complicated with Peritoneal Cysts Difficult toDifferentiate from Brenner tumor of the Ovary
Masafumi Katakura（Toho University Omori Medical Center）et al.

ISP―64― 2. A case of Leiomyomatosis peritonealis desseminata（LPD）
Kana Kasai（Tokushima University）et al.

ISP―64― 3. Effect of uterine artery embolization using by microspheres：review of 129 cases
Gen Ishikawa（Nippon Medical School）et al.

ISP―64― 4. Treatment outcomes of uterine artery embolization with microspheres for
symptomatic fibroids：a single!
center experience
Kyoso Ishida（Osaka University）et al.

ISP―64― 5. Introduction and Experience to Uterine Artery Embolization
Yousuke Sakai（Tokyo Medical University Hospital）et al.

― 117 ―

日㈮プログラム

females11